Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Elisabeth Livingstone

Funktionen

  • Assistenzarzt/-ärztin, Klinik für Dermatologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Albahri, Mohamed; Sauter, Daniel; Nensa, Felix; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Kukuk, Markus
    A new approach combining a whole-slide foundation model and gradient boosting for predicting BRAF mutation status in dermatopathology
    In: Computational and Structural Biotechnology Journal, Jg. 27, 2025, S. 2503 – 2514
    DOI (Open Access)
  • Borgers, Jessica S.W.; Johnson, Douglas B.; Livingstone, Elisabeth; Schadendorf, Dirk; Buchbinder, Elizabeth I.; Haydu, Lauren E.; Gohil, Laura; Robinson, William A.; Mehmi, Inderjit; Hamid, Omid; Ferreira, Michelle; Salama, April K.S.; Dimitriou, Florentia; Carlino, Matteo S.; Long, Georgina V.; Ascierto, Paolo A.; Simeone, Ester; Najjar, Yana G.; Hospers, Geke A.P.; Choi, Jacob; Chandra, Sunandana; Wayne, Jeffrey D.; García, Carlos I.R.; Xu, Wen; Lebbé, Céleste; Da-Meda, Laetitia; Atkinson, Victoria; Mckean, Meredith; Forschner, Andrea; Asare, Elliot A.; Daletzakis, Antonios; Taylor, Jolyn S.; Amant, Frédéric; Tsai, Katy K.; Eroglu, Zeynep; Haanen, John B.A.G.; Glitza de Oliva, Isabella C.
    Advanced stage melanoma during pregnancy : recommendations from a retrospective, multicentre, registry-based study
    In: eClinicalMedicine, Jg. 89, 2025, 103501
    DOI (Open Access)
  • Idrissi-Yaghir, Ahmad; Schäfer, Henning; Damm, Hendrik; Lodde, Georg C.; Livingstone, Elisabeth; Schadendorf, Dirk; Friedrich, Christoph M.
    Comparative analysis of international melanoma guidelines
    In: EJC Skin Cancer, Jg. 3, 2025, 100732
    DOI (Open Access)
  • Borys, Katarzyna; Lodde, Georg; Livingstone, Elisabeth; Weishaupt, Carsten; Römer, Christian; Künnemann, Marc-David; Helfen, Anne; Zimmer, Lisa; Galetzka, Wolfgang; Haubold, Johannes; Friedrich, Christoph M.; Umutlu, Lale; Heindel, Walter; Schadendorf, Dirk; Hosch, René; Nensa, Felix
    Correction : Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
    In: Journal of Translational Medicine, Jg. 23, 2025, Nr. 1, 596
    DOI (Open Access)
  • Yin, Menghong; Srinivas, Nalini; Lei, Kuan Cheok; Murad, Muhammad; Ugurel, Selma; Livingstone, Elisabeth; Hyun, Julia; Gambichler, Thilo; Rached, Nessr Abu; Becker, Jürgen C.
    Crosstalk between CLL and cutaneous T-cell lymphoma : MIF-CD74 axis and dysregulated inflammatory signaling
    In: EJC Skin Cancer, Jg. 3, 2025, 100735
    DOI (Open Access)
  • Livingstone, Elisabeth; Gogas, H.J.; Kandolf, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.; Gesierich, A.; Herbst, R.A.; Kähler, K.C.; Ziogas, D.C.; Mijušković, Ž.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel, Selma; Gutzmer, R.; Gaudy-Marqueste, C.; Kiecker, F.; Utikal, J.; Hartmann, M.; Miethe, S.; Eckhardt, S.; Zimmer, Lisa; Schadendorf, Dirk
    Early switch from run-in with targeted to immunotherapy in advanced BRAFV⁶⁰⁰-positive melanoma : final results of the randomised phase II ImmunoCobiVem trial
    In: ESMO Open, Jg. 10, 2025, Nr. 5, 105053
    DOI (Open Access)
  • Tomsitz, Dirk; Livingstone, Elisabeth; Loquai, Carmen; Kaatz, Martin; Leiter, Ulrike; Schilling, Bastian; Terheyden, Patrick; Hassel, Jessica; Sachse, Michael; Ulrich, Jens; Dippel, Edgar; Meiss, Frank; Pföhler, Claudia; Kreuter, Alexander; Herbst, Rudolf; Weichenthal, Michael; Zimmer, Lisa; Meier, Friedegund; Rauschenberg, Ricarda; Mohr, Peter; Brunnert, Fiona; von Wasielewski, Imke; Gutzmer, Ralf; Schadendorf, Dirk; Berking, Carola; Ugurel, Selma; Heinzerling, Lucie
    Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
    In: Journal of the European Academy of Dermatology and Venereology, Jg. 39, 2025, Nr. 11, S. 1975 – 1986
    DOI (Open Access)
  • Ziemer, Mirjana; Livingstone, Elisabeth
    Exanthematische Arzneimittelreaktionen
    In: Die Pathologie, Jg. 46, 2025, Nr. 2, S. 90 – 100
    DOI (Open Access)
  • Zillikens, Hannah; Scheib, Corinna; Peller, Vicky; Müller, Christina; Bauer, Sebastian; Pretzell, Ina; Griewank, Klaus; Sucker, Antje; Hadaschik, Eva; Guntrum, Felicitas; Baum, Sven Holger; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation loss
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), 2025, in press
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Seier, Johanna Andrea; Schielke, Lisa; Albrecht, Jessica Lea; Zimmer, Lisa; Livingstone, Elisabeth; Zaremba-Montenari, Anne; Lodde, Georg; Dissemond, Joachim; Sondermann, Wiebke; Krefting, Frederik; Tasdogan, Alpaslan; Rösch, Alexander; Hadaschik, Eva; Rambow, Florian; Griewank, Klaus; Ugurel, Selma; Schadendorf, Dirk; Placke, Jan-Malte
    Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients
    In: Frontiers in Immunology, Jg. 16, 2025, 1727312
    DOI (Open Access)
  • Borys, Katarzyna; Lodde, Georg; Livingstone, Elisabeth; Weishaupt, Carsten; Römer, Christian; Künnemann, Marc-David; Helfen, Anne; Zimmer, Lisa; Galetzka, Wolfgang; Haubold, Johannes; Friedrich, Christoph M.; Umutlu, Lale; Heindel, Walter; Schadendorf, Dirk; Hosch, René; Nensa, Felix
    Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
    In: Journal of Translational Medicine, Jg. 23, 2025, Nr. 1, 532
    DOI (Open Access)
  • Weichenthal, Michael; Ellebaek, Eva; Mangana, Joanna; Asher, Nethanel; Gavrilova, Iva; Kandolf, Lidija; Ugurel, Selma; Hausschild, Axel; Meier, Friedegund; Leiter, Ulrike; Livingstone, Elisabeth; Gebhardt, Christoffer; Gutzmer, Ralf; Ruhlmann, Christina H.; Mahncke-Guldbrandt, Louise; Haslund, Charlotte A.; Kopec, Sylwia; Teterycz, Paweł; Bender, Marc; Poudroux, Wilfried; Muñoz-Couselo, Eva; Berciano-Guerrero, Miguel-Angel; Shalamanova, Gergana; DePalo, Danielle K.; Brozić, Jasmina Marić; Chiarion-Sileni, Vanna; Arance, Anna; Ziogas, Dimitrios; Robert, Caroline; van de Velde, Anthonie Obik; Gassama, Awa Aminata; Shapira, Ronnie; BenBetzalel, Guy; Grynberg, Shirly; Ramelyte, Egle; Bertoldo, Fabio; DelPrete, Valerio; Gaudy-Marqueste, Caroline; Mohr, Peter; Dummer, Reinhard; Ascierto, Paolo A.; Gogas, Helen; Espinosa, Enrique; Lebbé, Celeste; Rutkowski, Piotr; Haanen, John; Schadendorf, Dirk; Svane, Inge Marie
    Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment : A EUMelaReg real-world evidence study
    In: European Journal of Cancer (EJC), Jg. 220, 2025, 115339
    DOI
  • Kött, Julian; Zell, Tim; Zimmermann, Noah; Rünger, Alessandra; Smit, Daniel J.; Abeck, Finn; Geidel, Glenn; Hansen-Abeck, Inga; Heidrich, Isabel; Weichenthal, Michael; Ugurel, Selma; Leiter, Ulrike; Berking, Carola; Gutzmer, Ralf; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth; von Wasielewski, Imke; Mohr, Peter; Meier, Friedegund; Haferkamp, Sebastian; Drexler, Konstantin; Herbst, Rudolf; Kellner, Ivonne; Utikal, Jochen; Wohlfeil, Sebastian A.; Pföhler, Claudia; Adam, Leonie; Terheyden, Patrick; Ulrich, Jens; Meiss, Frank; Möbes, Monica; Welzel, Julia; Schilling, Bastian; Ziller, Fabian; Kaatz, Martin; Kreuter, Alexander; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Weishaupt, Carsten; Hüning, Svea; Heinzerling, Lucie; Loquai, Carmen; Schley, Gaston; Gambichler, Thilo; Löffler, Harald; Grabbe, Stephan; Schultz, Erwin; Devereux, Nina; Hassel, Jesscia C.; Simon, Jan-Ch.; Raap, Ulrike; Assaf, Chalid; Klemke, Claus-Detlev; Sunderkötter, Cord; Hofmann, Silke C.; Wenk, Saskia; Tronnier, Michael; Thies, Silke; Heppt, Markus V.; Eggermont, Alexander; Schulze, Hans-Joachim; Zouboulis, Christos C.; Tüting, Thomas; Bauer, Alexander T.; Schneider, Stefan W.; Gebhardt, Christoffer
    Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy : A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg
    In: European Journal of Cancer (EJC), Jg. 214, 2025, 115159
    DOI (Open Access)
  • Lodde, Georg C.; Hassel, Jessica C.; Von Wasielewski, Imke; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Hauschild, Axel; Glutsch, Valerie; Stege, Henner; Berking, Carola; Hüning, Svea; Huynh, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Schilling, Bastian; Loquai, Carmen; Erdmann, Michael; Stang, Andreas; Kowall, Bernd; Galetzka, Wolfgang; Rösch, Alexander; Tilkorn, Daniel; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Forschner, Andrea; Livingstone, Elisabeth
    Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients with Stage III Melanoma
    In: Journal of Clinical Oncology (JCO), Jg. 43, 2025, Nr. 25, S. 2793 – 2805
    DOI
  • Elsayad, Khaled; Kandler, Christian; Siats, Jan Jakob; Pepper, Niklas; Danzer, Moritz Fabian; Dobos, Gabor; Livingstone, Elisabeth; Melchers, Susanne; Kleemann, Johannes; Hyun, Julia; Pföhler, Claudia; von den Driesch, Peter; Nicolay, Jan P.; Stadler, Rudolf; Eich, Hans Theodor
    Low-dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome : Results From the Prospective S-MISR Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), 2025, in press
    DOI (Open Access)
  • Tüller, Pia; Kiefer, Tobias; Jabbarli, Leyla; Papaioannou, Kyriaki; Schramm, Kathrin; Barwinski, Nicole; Schönberger, Stefan; Brecht, Ines B.; Schneider, Dominik T.; Livingstone, Elisabeth; Zimmer, Lisa; Fischhuber, Karen; Junker, Andreas; Ting, Saskia; Kiewert, Cordula; Göricke, Sophia; Bechrakis, Nikolaos; Biewald, Eva; Ketteler, Petra
    Melanoma of the Choroid and Ciliary Body in Children : Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint Inhibition
    In: Pediatric Blood and Cancer, 2025, e32147 , in press
    DOI (Open Access)
  • Skoda, E.-M.; Jansen, C.; Peltz, L.; Schweda, A.; Teufel, Martin; Livingstone, Elisabeth; Zimmer, Lisa; Forschner, A.; Reitmajer, M.; Erdmann, M.; Susok, L.; Rompel, R.; Debus, D.; Peitsch, W.K.; Garza Vazquez, X.; Raguz, J.; Harth, W.; Grabbe, S.; Meier, F.; Kaminski, K.; Tagari, E.; Schober, K.; Schadendorf, Dirk
    Needs, distress, state-of-health and quality-of-life in survivors of stage III melanoma : Results from the cross-sectional MESSAGE study
    In: EJC Skin Cancer, Jg. 3, 2025, 100754
    DOI (Open Access)
  • Kähler, K.C.; Hassel, J.C.; Ziemer, M.; Rutkowski, P.; Meier, F.; Flatz, L.; Gaudy-Marqueste, C.; Zimmer, Lisa; Santinami, M.; Russano, F.; von Wasielewski, I.; Eigentler, T.K.; Maio, M.; Zalaudek, I.; Haferkamp, S.; Quaglino, P.; Welzel, J.; Röcken, C.; Enk, A.; Simon, J.-C.; Świtaj, T.; Garzarolli, M.; Amaral, T.; Malissen, N.; Livingstone, Elisabeth; Elia, G.; Covelli, A.; Lorizzo, K.; Neri, D.; Mulatto, S.; Parca, A.; Pizzichi, B.; Ascierto, P.A.; Garbe, C.; Robert, C.; Schadendorf, Dirk; Hauschild, A.
    Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma
    In: Annals of Oncology, Jg. 36, 2025, Nr. 10, S. 1166 – 1177
    DOI (Open Access)
  • Placke, Jan-Malte; Rajcsanyi, Luisa Sophie; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Weichenthal, Michael; Meier, Friedegund; Berking, Carola; Leiter, Ulrike; Seier, Johanna; Krefting, Frederik; Tasdogan, Alpaslan; Lodde, Georg; Livingstone, Elisabeth; Zimmer, Lisa; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Ugurel, Selma
    Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status
    In: Frontiers in Immunology, Jg. 16, 2025, 1536642
    DOI, Online Volltext (Open Access)
  • Küper, Alisa; Lodde, Georg Christian; Livingstone, Elisabeth; Schadendorf, Dirk; Krämer, Nicole
    Psychological Factors Influencing Appropriate Reliance on AI-enabled Clinical Decision Support Systems : Experimental Web-Based Study Among Dermatologists
    In: Journal of Medical Internet Research (JMIR), Jg. 27, 2025, e58660
    DOI (Open Access)
  • Sauer, Christina; Ullerich, Cathrin; Livingstone, Elisabeth; Tagay, Sefik; Bugaj, Till J.; Skoda, Eva-Maria; Teufel, Martin; Schadendorf, Dirk; Friederich, Hans-Christoph
    Psychosocial distress and psychosocial resources in couples facing non-melanoma skin cancers and malignant melanoma
    In: Journal of Psychosocial Oncology, Jg. 43, 2025, Nr. 2, S. 173 – 188
    DOI
  • DeTemple, Viola K.; Kaatz, Martin; Stockfleth, Eggert; Scheel, Christina; Angela, Yenny; Gutzmer, Ralf; Leiter, Ulrike; Meier, Friedegund; Schadendorf, Dirk; Livingstone, Elisabeth; Gebhardt, Christoffer; von Wasielewski, Imke; Weichenthal, Michael; Mohr, Peter; Hassel, Jessica; Pföhler, Claudia; Simon, Jan Christoph; Jochims, Franziska; Terheyden, Patrick; Ulrich, Jens; Haferkamp, Sebastian; Drexler, Konstantin; Schilling, Bastian; Glutsch, Valerie; Heinzerling, Lucie; Berking, Carola; Ugurel, Selma; Tomsitz, Dirk
    Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma
    In: European Journal of Cancer (EJC), Jg. 225, 2025, 115590
    DOI (Open Access)
  • Reitmajer, Markus; Livingstone, Elisabeth; Heinzerling, Lucie; Thoms, Kai-Martin; Meiss, Frank; Heppt, Markus V.; Gesierich, Anja; Drexler, Konstantin; Meier, Friedegund; Schlaak, Max; Forschner, Andrea; Zimmer, Lisa
    Real-world management of adjuvant systemic melanoma therapy : Multi-center survey of 51 DeCOG skin cancer centers
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), 2025, in press
    DOI (Open Access)
  • Reitmajer, Markus; Livingstone, Elisabeth; Thoms, Kai-Martin; Heppt, Markus V.; Meiss, Frank; Gesierich, Anja; Drexler, Konstantin; Heinzerling, Lucie; Meier, Friedegund; Menzer, Christian; Schlaak, Max; Zimmer, Lisa; Forschner, Andrea
    Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 23, 2025, Nr. 3, S. 321 – 327
    DOI (Open Access)
  • Reitmajer, Markus; Livingstone, Elisabeth; Thoms, Kai‐Martin; Heppt, Markus V.; Meiss, Frank; Gesierich, Anja; Drexler, Konstantin; Heinzerling, Lucie; Meier, Friedegund; Menzer, Christian; Schlaak, Max; Zimmer, Lisa; Forschner, Andrea
    Real‐world management bei Patienten mit Komplettremission unter Immuncheckpoint‐Inhibition bei fortgeschrittenem Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 23, 2025, Nr. 3, S. 321 – 329
    DOI (Open Access)
  • Idrissi-Yaghir, Ahmad; Schäfer, Henning; Damm, Hendrik; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Friedrich, Christoph M.
    Response to Letter: Re: “Comparative analysis of international melanoma guidelines”
    In: EJC Skin Cancer, Jg. 3, 2025, 100752
    DOI (Open Access)
  • Srinivas, Nalini; Spassova, Ivelina; Lei, Kuan Cheok; Gao, Jiwei; Pino, María José; Giglio, Giovanni; Kitanovski, Simo; Dalkoohi, Mazdak; Livingstone, Elisabeth; Leiter, Ulrike; Mohr, Peter; Gambichler, Thilo; Stoffels, Ingo; Ugurel, Selma; Cheung, Phyllis Fung-Yi; Engblom, Camilla; Lui, Weng-Onn; Becker, Jürgen Christian
    Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response
    In: Journal for ImmunoTherapy of Cancer, Jg. 13, 2025, Nr. 9, S. e012224
    DOI (Open Access)
  • Jansen, Philipp; Galetzka, Wolfgang; Thielmann, Carl Maximilian; Murali, Rajmohan; Zaremba-Montenari, Anne; Standl, Fabian; Lodde, Georg; Möller, Inga; Sucker, Antje; Paschen, Annette; Hadaschik, Eva; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Stang, Andreas; Griewank, Klaus
    pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy
    In: European Journal of Cancer (EJC), Jg. 220, 2025, 115337
    DOI (Open Access)
  • Sauter, Daniel; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, Markus
    A Systematic Comparison of Task Adaptation Techniques for Digital Histopathology
    In: Bioengineering, Jg. 11, 2024, Nr. 1, 19
    DOI (Open Access)
  • Albrecht, Jessica Lea; Dimitriou, Florentia; Grover, Piyush; Hassel, Jessica C.; Erdmann, Michael; Forschner, Andrea; Johnson, Douglas B.; Váraljai, Renáta; Lodde, Georg; Placke, Jan-Malte; Krefting, Frederik; Zaremba, Anne; Ugurel, Selma; Rösch, Alexander; Schulz, Carsten; Berking, Carola; Pöttgen, Christoph; Menzies, Alexander M.; Long, Georgina V.; Dummer, Reinhard; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa
    Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
    In: European Journal of Cancer (EJC), Jg. 202, 2024, 113976
    DOI (Open Access)
  • Ziemer, Mirjana; Livingstone, Elisabeth
    Arzneimittelexantheme unter Immun- und zielgerichteter onkologischer Therapie
    In: Die Dermatologie, Jg. 75, 2024, Nr. 6, S. 440 – 450
    DOI
  • Chorti, Eleftheria; Kowall, Bernd; Hassel, Jessica C.; Schilling, Bastian; Sachse, Michael; Gutzmer, Ralf; Loquai, Carmen; Kähler, Katharina C.; Hüsing, Anika; Gilde, Catharina; Thielmann, Carl Maximilian; Zaremba-Montenari, Anne; Placke, Jan-Malte; Gratsias, Emmanouil; Martaki, Anna; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Stang, Andreas; Zimmer, Lisa
    Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade
    In: European Journal of Cancer (EJC), Jg. 200, 2024, 113536
    DOI (Open Access)
  • Schäfer, Henning; Idrissi-Yaghir, Ahmad; Arzideh, Kamyar; Damm, Hendrik; Pakull, Tabea M.G.; Schmidt, Cynthia S.; Bahn, Mikel; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Nensa, Felix; Horn, Peter; Friedrich, Christoph M.
    BioKGrapher : Initial evaluation of automated knowledge graph construction from biomedical literature
    In: Computational and Structural Biotechnology Journal, Jg. 24, 2024, S. 639 – 660
    DOI (Open Access)
  • Krueger, Oskar; Eisenburger, Robin; Tasdogan, Alpaslan; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Theurer, Sarah; Brodin, Berthold; Schadendorf, Dirk; Ugurel, Selma
    Case report: : Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab
    In: Frontiers in Immunology, Jg. 15, 2024, 1369190
    DOI, Online Volltext (Open Access)
  • Matull, Johanna; Placke, Jan-Malte; Lodde, Georg; Zaremba-Montenari, Anne; Utikal, Jochen; Terheyden, Patrick; Pföhler, Claudia; Herbst, Rudolf; Kreuter, Alexander; Welzel, Julia; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Thielmann, Carl Maximilian; Griewank, Klaus
    Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
    In: Frontiers in Immunology, Jg. 15, 2024, 1383125
    DOI (Open Access)
  • Lodde, Georg; Zhao, Fang; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Jansen, Philipp; Kowall, Bernd; Galetzka, Wolfgang; Hörst, Fabian; Kleesiek, Jens; Hellwig, Birte; Rahnenführer, Jörg; Rajcsanyi, Luisa; Peters, Triinu; Hinney, Anke; Placke, Jan-Malte; Sucker, Antje; Paschen, Annette; Becker, Jürgen; Livingstone, Elisabeth; Zimmer, Lisa; Tasdogan, Alpaslan; Rösch, Alexander; Hadaschik, Eva; Schadendorf, Dirk; Griewank, Klaus; Ugurel, Selma
    Early versus late response to PD-1-based immunotherapy in metastatic melanoma
    In: European Journal of Cancer (EJC), Jg. 210, 2024, 114295
    DOI (Open Access)
  • Tarantino, Giuseppe; Ricker, Cora A.; Wang, Annette; Ge, William; Aprati, Tyler J.; Huang, Amy Y.; Madha, Shariq; Chen, Jiajia; Shi, Yingxiao; Glettig, Marc; Feng, Catherine H.; Frederick, Dennie T.; Freeman, Samuel; Holovatska, Marta M.; Manos, Michael P.; Zimmer, Lisa; Rösch, Alexander; Zaremba, Anne; Livingstone, Elisabeth; Jameson, Jacob C.; Saghafian, Soroush; Lee, Andrew; Zhao, Karena; Morris, Luc G.T.; Reardon, Brendan; Park, Jihye; Elmarakeby, Haitham A.; Schilling, Bastian; Giobbie-Hurder, Anita; Vokes, Natalie I.; Buchbinder, Elizabeth I.; Flaherty, Keith T.; Haq, Rizwan; Wu, Catherine J.; Boland, Genevieve M.; Hodi, F. Stephen; Van Allen, Eliezer M.; Schadendorf, Dirk; Liu, David
    Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
    In: Science Advances, Jg. 10, 2024, Nr. 48, eadp4670
    DOI (Open Access)
  • Schirren, A.E.C.; Albrecht, J.D.; Melchers, S.; Weiß, C.; Büttner, S.; Dippel, E.; Gosmann, J.; Jonak, C.; Klemke, C.-D.; Laturnus-Chang, M.; Livingstone, Elisabeth; Mitteldorf, C.; Schummer, P.; Stadler, R.; Stranzenbach, R.; Weyer-Fahlbusch, S.S.; Wobser, M.; Ziemer, M.; Nicolay, J.P.
    Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas : A multicentric study in 100 patients
    In: Journal of the European Academy of Dermatology and Venereology, Jg. 38, 2024, Nr. 5, S. 954 – 966
    DOI (Open Access)
  • Küper, Alisa; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Krämer, Nicole
    Mitigating cognitive bias with clinical decision support systems : An experimental study
    In: Journal of Decision Systems, Jg. 33, 2024, Nr. 3, S. 439 – 458
    DOI
  • Albrecht, Jessica Lea; Grünwald, Viktor; Becker, Jürgen; Gutzmer, Ralf; Asan, Livia; Uslar, Ellen; Eilers, Alexandra; Müseler, Anne-Christine; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    PTHrP-induced hypercalcemic psychosyndrome under combined anti-PD-L1 and anti-EGFR inhibition in penile squamous cell carcinoma : A case report
    In: EJC Skin Cancer, Jg. 2, 2024, 100261
    DOI (Open Access)
  • Hansen-Abeck, Inga; Geidel, Glenn; Abeck, Finn; Kött, Julian; Cankaya, Rohat; Dobos, Gabor; Mitteldorf, Christina; Nicolay, Jan P.; Albrecht, Jana D.; Menzer, Christian; Livingstone, Elisabeth; Mengoni, Miriam; Braun, Andreas D.; Wobser, Marion; Klemke, Claus-Detlev; Tratzmiller, Sabine; Assaf, Chalid; Terheyden, Patrick; Klespe, Kai-Christian; Schneider, Stefan W.; Booken, Nina
    Pegylated interferon-α2a in cutaneous T-cell lymphoma : a multicenter retrospective data analysis with 70 patients
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 22, 2024, Nr. 11, S. 1489 – 1497
    DOI (Open Access)
  • Kähler, Katharina C.; Gutzmer, Ralf; Angela, Yenny; Livingstone, Elisabeth; Lodde, Georg; Meiss, Frank; Rafei-Shamsabadi, David A.; Weyer-Fahlbusch, Sera S.; Nashan, Dorothée; Loquai, Carmen; Hassel, Jessica C.; Sachse, Michael M. M.; Maul, Lara V.; Heinzerling, Lucie; Heppt, Markus V.; Colapietro, Chiara; Rusch, Judith; Blome, Christine
    Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A) : The doctors’ perspective
    In: Journal of Cancer Research and Clinical Oncology, Jg. 150, 2024, Nr. 5, 252
    DOI (Open Access)
  • Hartmann, Eva Maria; Küper, Alisa; Swoboda, Jessica; Lodde, Georg; Livingstone, Elisabeth; Beckmann, Catharina Lena; Schadendorf, Dirk; Sachweh, Sabine
    Requirements for a dashboard optimized for melanoma patient care through user-centered context exploration
    In: Scientific Reports, Jg. 14, 2024, Nr. 1, 17471
    DOI (Open Access)
  • Jansen, Philipp; Galetzka, Wolfgang; Lodde, Georg; Standl, Fabian; Zaremba-Montenari, Anne; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Placke, Jan-Malte; Landsberg, Jennifer; Möller, Inga; Sucker, Antje; Paschen, Annette; Hadaschik, Eva; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Stang, Andreas; Griewank, Klaus
    Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas
    In: European Journal of Cancer (EJC), Jg. 208, 2024, 114208
    DOI (Open Access)
  • Srinivas, Nalini; Peiffer, Lukas; Horny, Kai; Lei, Kuan Cheok; Buus, Terkild B.; Kubat, Linda; Luo, Meng; Yin, Menghong; Spassova, Ivelina; Sucker, Antje; Farahpour, Farnoush; Kehrmann, Jan; Ugurel, Selma; Livingstone, Elisabeth; Gambichler, Thilo; Ødum, Niels; Becker, Jürgen C.
    Single-cell RNA and T-cell receptor sequencing unveil mycosis fungoides heterogeneity and a possible gene signature
    In: Frontiers in Oncology, Jg. 14, 2024, 1408614
    DOI (Open Access)
  • Winkler, Manuel; Albrecht, Jana Dorothea; Sauer, Christian; Kordaß, Theresa; Guenova, Emmanuella; Livingstone, Elisabeth; Wobser, Marion; Mitteldorf, Christina; Géraud, Cyrill; Nicolay, Jan Peter
    Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type : A case series and review of the literature
    In: The Journal of Dermatology, Jg. 51, 2024, Nr. 9, S. 1233 – 1239
    DOI (Open Access)
  • Swoboda, Jessica; Albert, Moritz; Beckmann, Catharina Lena; Lodde, Georg; Livingstone, Elisabeth; Nensa, Felix; Schadendorf, Dirk; Böckmann, Britta
    The Mappability of Clinical Real-World Data of Patients with Melanoma to Oncological Fast Healthcare Interoperability Resources (FHIR) Profiles : A Single-Center Interoperability Study
    In: Informatics, Jg. 11, 2024, Nr. 3, 42
    DOI, Online Volltext (Open Access)
  • Schaper-Gerhardt, Katrin; Gutzmer, Ralf; Angela, Yenny; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Hassel, Jessica C.; Weishaupt, Carsten; Remes, Bernhard; Kubat, Linda; Spassova, Ivelina; Becker, Jürgen
    The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
    In: European Journal of Cancer (EJC), Jg. 202, 2024, 113984
    DOI (Open Access)
  • Krefting, Frederik; Livingstone, Elisabeth; Sondermann, Wiebke; Thielmann, Carl M.; Placke, Jan-Malte; Schadendorf, Dirk; Polan, Christina; Rath, Peter-Michael; Scharmann, Ulrike; Uhrlaß, Silke; Nenoff, Pietro
    Tinea capitis due to Trichophyton soudanense and Microsporum audouinii : A surprising finding
    In: JEADV Clinical Practice, Jg. 3, 2024, Nr. 3, Skin Diversity, S. 887 – 890
    DOI, Online Volltext (Open Access)
  • Beckmann, Catharina Lena; Lodde, Georg; Swoboda, Jessica; Livingstone, Elisabeth; Böckmann, Britta
    Use of Real-World FHIR Data Combined with Context-Sensitive Decision Modeling to Guide Sentinel Biopsy in Melanoma
    In: Journal of Clinical Medicine (JCM), Jg. 13, 2024, Nr. 11, 3353
    DOI (Open Access)
  • Becker, Jürgen; Ugurel, Selma; Leiter, Ulrike; Meier, Friedegund; Gutzmer, Ralf; Haferkamp, Sebastian; Zimmer, Lisa; Livingstone, Elisabeth; Eigentler, Thomas K; Hauschild, Axel; Kiecker, Felix; Hassel, Jessica C; Mohr, Peter; Fluck, Michael; Thomas, Ioannis; Garzarolli, Marlene; Grimmelmann, Imke; Drexler, Konstantin; Spillner, Alexandra N; Eckhardt, Sebastian; Schadendorf, Dirk; van Akkoi, Alexander; van Houdt, Winan; Wilhelm, Tabea; Farmer, Kimberly; Ulrich, Claas; Gambichler, Thilo; Bluhm, Leonie; Schinagl, Heidemarie; Kellner, Ivonne; Herbst, Rudolf; Meiß, Frank; Rafei-Shamsabadi, David; Sell, Sabine; Kaatz, Martin; Wulfken, Lena; Hartmann, Martin; Kähler, Katharina; Ziemer, Mirjana; Simon, Jan; Terheyden, Patrick; Thaci, Diamant; Loquai, Carmen; Mitzel-Rink, Heidrun; Grabbe, Stephan; Stege, Henner; Gaiser, Maria; Utikal, Jochen; Berking, Carola; Heinzerling, Lucie; Schlaak, Max; Tomsitz, Dirk; Dyballa, Jörg; Magnolo, Nina; Weishaupt, Carsten; Berneburg, Mark; Garbe, Claus; Flatz, Lukas; Gesierich, Anja; Schilling, Bastian
    Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O) : disease-free survival results from a randomised, open-label, phase 2 trial
    In: Lancet, Jg. 402, 2023, Nr. 10404, S. 798 – 808
    DOI
  • Lodde, Georg; Hassel, Jessica; Wulfken, Lena M.; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Hauschild, Axel; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Beckmann, Catharina L.; Stang, Andreas; Kowall, Bernd; Galetzka, Wolfgang; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Forschner, Andrea; Livingstone, Elisabeth
    Adjuvant treatment and outcome of stage III melanoma patients : Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
    In: European Journal of Cancer (EJC), Jg. 191, 2023, 112957
    DOI
  • Váraljai, Renáta; Zimmer, Lisa; Al-Matary, Yahya; Kaptein, Paulien; Albrecht, Lea J.; Shannan, Batool; Brase, Jan C.; Gusenleitner, Daniel; Amaral, Teresa; Wyss, Nina; Utikal, Jochen; Flatz, Lukas; Rambow, Florian; Reinhardt, Hans Christian; Dick, Jenny; Engel, Daniel R.; Horn, Susanne; Ugurel, Selma; Sondermann, Wiebke; Livingstone, Elisabeth; Sucker, Antje; Paschen, Annette; Zhao, Fang; Placke, Jan M.; Klose, Jasmin M.; Fendler, Wolfgang P.; Thommen, Daniela S.; Helfrich, Iris; Schadendorf, Dirk; Rösch, Alexander
    Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
    In: Nature Cancer, Jg. 4, 2023, Nr. 9, S. 1395
    DOI (Open Access)
  • Lee, Joanna; Ahmed, Tasnia; Maurichi, Andrea; Di Guardo, Lorenzo; Stagno, Anna M.; Warburton, Lydia; Taylor, Amelia. M.; Livingstone, Elisabeth; Rehman, Saba; Khattak, Adnan; Kahler, Katharina C.; Vanella, Vito; Atkinson, Victoria; Millward, Michael; Schadendorf, Dirk; Johnson, Douglas B.; Ascierto, Paolo A.; Hauschild, Axel; Lo, Serigne N.; Long, Georgina V.; Menzies, Alexander M.; Carlino, Matteo S.; Di Guardo, Lorenza
    BRAF inhibitor cessation prior to disease progression in metastatic melanoma : Long-term outcomes
    In: European Journal of Cancer (EJC), Jg. 179, 2023, S. 87 – 97
    DOI
  • Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Kähler, Katharina; Grimmelmann, Imke; Gutzmer, Ralf; Utikal, Jochen; Terheyden, Patrick; Herbst, Rudolf; Haferkamp, Sebastian; Pfoehler, Claudia; Forschner, Andrea; Leiter, Ulrike; Ziller, Fabian; Meiss, Frank; Ulrich, Jens; Kreuter, Alexander; Gebhardt, Christoffer; Welzel, Julia; Schilling, Bastian; Kaatz, Martin; Scharfetter-Kochanek, Karin; Dippel, Edgar; Nashan, Dorothee; Sachse, Michael; Weishaupt, Carsten; Löffler, Harald; Gambichler, Thilo; Loquai, Carmen; Heinzerling, Lucie; Grabbe, Stephan; Debus, Dirk; Schley, Gaston; Hassel, Jessica C.; Weyandt, Gerhard; Trommer, Maike; Lodde, Georg; Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen Christian; Horn, Susanne; Schadendorf, Dirk; Ugurel, Selma
    Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer, Jg. 11, 2023, Nr. 4
    DOI (Open Access)
  • Berking, Carola; Livingstone, Elisabeth; Debus, Dirk; Loquai, Carmen; Weichenthal, Michael; Leiter, Ulrike; Kiecker, Felix; Mohr, Peter; Eigentler, Thomas K.; Remy, Janina; Schober, Katharina; Heppt, Markus V.; von Wasielewski, Imke; Schadendorf, Dirk; Gutzmer, Ralf
    COMBI-r : A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma
    In: Cancers, Jg. 15, 2023, Nr. 18, 4436
    DOI (Open Access)
  • Lodde, Georg C.; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Sucker, Antje; Placke, Jan-Malte; Zaremba, Anne; Albrecht, Lea Jessica; Kowall, Bernd; Galetzka, Wolfgang; Becker, Jürgen C.; Tasdogan, Alpaslan; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma; Griewank, Klaus
    Characterisation and outcome of RAC1 mutated melanoma
    In: European Journal of Cancer (EJC), Jg. 183, 2023, S. 1 – 10
    DOI
  • Placke, Jan-Malte; Kimmig, Mona; Griewank, Klaus; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Welzel, Julia; Engel, Daniel Robert; Kreft, Sophia; Sucker, Antje; Lodde, Georg; Krefting, Frederik; Stoffels, Ingo; Klode, Joachim; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Becker, Jürgen; Weichenthal, Michael; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma
    Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma ADOREG/TRIM : Analysis of the DeCOG prospective multicenter cohort study
    In: eBioMedicine, Jg. 96, 2023, 104774
    DOI (Open Access)
  • Sauter, Daniel; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, Markus
    Deep learning in computational dermatopathology of melanoma : A technical systematic literature review
    In: Computers in Biology and Medicine, Jg. 163, 2023, 107083
    DOI (Open Access)
  • Livingstone, Elisabeth; Gogas, H.; Kandolf-Sekulovic, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.A.M.; Gesierich, A.H.; Herbst, R.A.; Kähler, K.C.; Ziogas, D.C.; Mijuskovic, Z.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel, Selma; Gutzmer, R.; Grob, J.J.; Kiecker, F.; Utikal, J.; Windemuth-Kieselbach, C.; Eckhardt, S.; Zimmer, Lisa; Schadendorf, Dirk
    Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma : The ImmunoCobiVem phase 2 randomised trial
    In: European Journal of Cancer (EJC), Jg. 190, 2023, 112941
    DOI
  • Wong, Selina K.; Blum, Steven M.; Sun, Xiaopeng; Da Silva, Inês P.; Zubiri, Leyre; Ye, Fei; Bai, Kun; Zhang, Kevin; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Serra-Bellver, Patricio; Muñoz-Couselo, Eva; Ortiz, Carolina; Lostes, Julia; Huertas, Roberto M.; Arance, Ana; Pickering, Lisa; Long, Georgina V.; Carlino, Matteo S.; Buchbinder, Elizabeth I.; Vázquez-Cortés, Leticia; Jara-Casas, Diego; Márquez-Rodas, Iván; González-Espinoza, Iván R.; Balko, Justin M.; Menzies, Alexander M.; Sullivan, Ryan J.; Johnson, Douglas B.
    Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
    In: European Journal of Cancer (EJC), Jg. 181, 2023, S. 188 – 197
    DOI
  • Bhave, Prachi; Hong, Angela; Lo, Serigne N.; Johnson, Rebecca; Mangana, Johanna; Johnson, Douglas B.; Dulgar, Ozgecan; Eroglu, Zeynep; Yeoh, Hui-Ling; Haydon, Andrew; Lodde, Georg C.; Livingstone, Elisabeth; Khattak, Adnan; Kähler, Katharina; Hausschild, Axel; McArthur, Grant A.; Menzies, Alexander Maxwell; Long, Georgina; Wang, Wei; Carlino, Matteo S.
    Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
    In: Journal for ImmunoTherapy of Cancer, Jg. 11, 2023, Nr. 3, e006629
    DOI (Open Access)
  • Livingstone, Elisabeth; Berking, Carola
    Fertilität, Teratogenität und Kontrazeption bei BRAF-/MEK-Inhibition
    In: Die Dermatologie, Jg. 74, 2023, Nr. 7, S. 496 – 500
    DOI
  • Zaremba, Anne; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Pföhler, Claudia; Weichenthal, Michael; Terheyden, Patrick; Forschner, Andrea; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen; Welzel, Julia; Kaatz, Martin; Gebhardt, Christoffer; Herbst, Rudolf; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Meiss, Frank; Heinzerling, Lucie; Haferkamp, Sebastian; Weishaupt, Carsten; Löffler, Harald; Kreft, Sophia; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa
    Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma : a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
    In: European Journal of Cancer (EJC), Jg. 188, 2023, S. 140 – 151
    DOI, Online Volltext (Open Access)
  • Váraljai, Renáta; Zimmer, Lisa; Al-Matary, Yahya; Kaptein, Paulien; Albrecht, Lea J.; Shannan, Batool; Brase, Jan C.; Gusenleitner, Daniel; Amaral, Teresa; Wyss, Nina; Utikal, Jochen; Flatz, Lukas; Rambow, Florian; Reinhardt, Hans Christian; Dick, Jenny; Engel, Daniel R.; Horn, Susanne; Ugurel, Selma; Sondermann, Wiebke; Livingstone, Elisabeth; Sucker, Antje; Paschen, Annette; Zhao, Fang; Placke, Jan-Malte; Klose, Jasmin M.; Fendler, Wolfgang; Thommen, Daniela S.; Helfrich, Iris; Schadendorf, Dirk; Rösch, Alexander
    Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
    In: Nature Cancer, Jg. 4, 2023, Nr. 9, S. 1292 – 1308
    DOI (Open Access)
  • Goodman, Rachel S.; Di Guardo, Lorenza; Maurichi, Andrea; Kirwin, Brendan; Khattak, Adnan; Vanella, Vito; Lee, Joanna; Lawless, Aleigha; Czapla, Juliane; Spagnoletti, Andrea; Ambrosini, Margherita; Livingstone, Elisabeth; Long, Georgina V.; Sullivan, Ryan J.; Carlino, Matteo S.; Atkinson, Victoria; Trojanello, Claudia; Ascierto, Paolo A.; Schadendorf, Dirk; Warburton, Lydia; Menzies, Alexander M.; Santinami, Mario; Johnson, Douglas B.
    Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma
    In: European Journal of Cancer (EJC), Jg. 194, 2023, 113354
    DOI
  • Kähler, Katharina C.; Hüning, S.; Nashan, D.; Meiss, F.; Rafei-Shamsabadi, D.A.; Rissmann, H.; Colapietro, C.; Livingstone, Elisabeth; Maul, L.V.; Heppt, M.; Hassel, J.C.; Gutzmer, R.; Loquai, C.; Heinzerling, L.; Sachse, M.M.; Bohne, A.S.; Moysig, L.; Peters, W.; Rusch, J.; Blome, C.
    Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
    In: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 13, S. 11705 – 11718
    DOI (Open Access)
  • Placke, Jan-Malte; Zahn, Maximilian; Zillikens, Hannah; Krefting, Frederik; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Sucker, Antje; Roesch, Alexander; Tasdogan, Alpaslan; Srinivas, Nalini K.; Schadendorf, Dirk; Becker, Jürgen C.; Ugurel, Selma
    Prognostic factors in the primary care of patients with Merkel cell carcinoma : A monocentric cohort study of 108 patients from a tertiary referral centre
    In: JEADV Clinical Practice, Jg. 2, 2023, Nr. 4, S. 810 – 818
    DOI, Online Volltext (Open Access)
  • Albrecht, Lea Jessica; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk
    The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma
    In: Current Oncology Reports, Jg. 25, 2023, Nr. 6, :647-657
    DOI (Open Access)
  • Troesch, Alexander; Magdalena, Hoellwerth; Forchhammer, Stephan; Del Regno, Laura; Lodde, Georg; Turko, Patrick; Cheng, Phil F.; Levesque, Mitchell L.; Hadaschik, Eva; Livingstone, Elisabeth; Peris, Ketty; Flatz, Lukas; Peter, Koelblinger; Dummer, Reinhard; Dimitriou, Florentia
    The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas : A retrospective cohort study from five European skin cancer reference centres
    In: Journal of the European Academy of Dermatology and Venereology, Jg. 37, 2023, Nr. 5, Special issue on melanoma: Immune check point and BRAF‐MEK inhibitors in melanoma, S. 922 – 931
    DOI (Open Access)
  • Elsayad, Khaled; Weishaupt, Carsten; Moustakis, Christos; Danzer, Moritz Fabian; Müller, Elisa Christina; Rolf, Daniel; Stranzenbach, Rene; Livingstone, Elisabeth; Booken, Nina; Stadler, Rudolf; Eich, Hans Theodor
    Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome
    In: International Journal of Radiation Oncology, Biology, Physics, Jg. 117, 2023, Nr. 1, S. 164 – 170
    DOI
  • Livingstone, Elisabeth; Zimmer, Lisa; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas K.; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kiecker, Felix; Dippel, Edgar; Rösch, Alexander; Ziemer, Mirjana; Conrad, Beate; Körner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Jürgen C.; Schadendorf, Dirk; Simon, Jan-Christoph; Herbst, Rudolf A.; Berking, Carola; Utikal, Jochen; Sell, Sabine; Martens, Uwe M.; Terheyden, Patrick; Stadler, Rudolf
    Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : Final results of a randomised, double-blind, phase 2 trial
    In: Lancet, Jg. 400, 2022, Nr. 10358, S. 1117 – 1129
    DOI
  • Lodde, Georg; Fiedler, Melanie; Dittmer, Ulf; Placke, Jan-Malte; Jansen, Philipp; Becker, Jürgen; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Sondermann, Wiebke; Ugurel, Selma
    COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment : A prospective singlecenter study investigating seroconversion rates
    In: Frontiers in Oncology, Jg. 12, 2022, 879876
    DOI, Online Volltext (Open Access)
  • Jansen, Philipp; Lodde, Georg; Wetter, Axel; Welt, Anja; Stuschke, Martin; Dührsen, U.; Stoffels, Ingo; Klode, Joachim; Livingstone, Elisabeth; Zimmer, Lisa; Rösch, Alexander; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Ugurel, Selma
    Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia : divergent outcomes in two men treated with PD-1 inhibitors
    In: Journal of the European Academy of Dermatology and Venereology, Jg. 36, 2022, Nr. S1: Anti PD-1 Therapy of Advanced Cutaneous Squamous Cell Carcinoma, S. 41 – 44
    DOI (Open Access)
  • Albrecht, Lea Jessica; Höwner, Anna; Griewank, Klaus; Lueong, Smiths S.; von Neuhoff, Nils; Horn, Peter; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, Susanne; Siveke, Jens T.; Schadendorf, Dirk; Váraljai, Renáta; Rösch, Alexander
    Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
    In: Clinical and Translational Medicine, Jg. 12, 2022, Nr. 11, e1090
    DOI, Online Volltext (Open Access)
  • Zaremba-Montenari, Anne; Meier, Friedegund; Schlein, Christian; Jansen, Philipp; Lodde, Georg; Song, Mingxia; Kretz, Julia; Möller, Inga; Stadtler, Nadine; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus
    Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants
    In: Pigment Cell and Melanoma Research, Jg. 35, 2022, Nr. 6, S. 573 – 586
    DOI (Open Access)
  • Kaatz, Martin; Mohr, Peter; Livingstone, Elisabeth; Weichenthal, Michael; Kreuter, Alexander; Pföhler, Claudia; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen Sven; Gutzmer, Ralf; Herbst, Rudolf; Schadendorf, Dirk
    Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions : Non-interventional Cohort Study JONAS
    In: Acta Dermato-Venereologica, Jg. 102, 2022, adv00695
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Matull, Johanna; Roth, Sebastian; Placke, Jan-Malte; Chorti, Eleftheria; Zaremba, Anne; Lodde, Georg; Jansen, Philipp; Krefting, Frederik; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus
    Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
    In: Cancers, Jg. 14, 2022, Nr. 9, 2090
    DOI, Online Volltext (Open Access)
  • Zaremba, Anne; Jansen, Philipp; Murali, Rajmohan; Mayakonda, Anand; Riedel, Anna; Krahl, Dieter; Burkhardt, Hans; John, Stefan; Géraud, Cyrill; Philip, Manuel; Kretz, Julia; Möller, Inga; Stadtler, Nadine; Sucker, Antje; Paschen, Annette; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Susanne; Plass, Christoph; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, Pavlo; Griewank, Klaus
    Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
    In: Cancers, Jg. 14, 2022, Nr. 17, 4066
    DOI, Online Volltext (Open Access)
  • Zaremba-Montenari, Anne; Jansen, Philipp; Murali, Rajmohan; Mayakonda, Anand; Riedel, Anna; Philip, Manuel; Rose, Christian; Schaller, Jörg; Müller, Hansgeorg; Kutzner, Heinz; Möller, Inga; Stadtler, Nadine; Kretz, Julia; Sucker, Antje; Bankfalvi, Agnes; Livingstone, Elisabeth; Zimmer, Lisa; Horn, Susanne; Paschen, Annette; Plass, Christoph; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, Pavlo; Griewank, Klaus
    Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors
    In: International Journal of Cancer, Jg. 151, 2022, Nr. 9, S. 1542 – 1554
    DOI (Open Access)
  • Lodde, Georg; Jansen, Philipp; Möller, Inga; Sucker, Antje; Hassel, Jessica C.; Forschner, Andrea; Eckardt, Julia; Meier, Friedegund; Reinhardt, Lydia; Kähler, Katharina C.; Ziemer, Mirjana; Schlaak, Max; Rahimi, Farnaz; Schatton, Kerstin; Meiss, Frank; Gutzmer, Ralf; Pföhler, Claudia; Terheyden, Patrick; Schilling, Bastian; Sachse, Michael; Heppt, Markus V.; Sindrilaru, Anca; Leiter, Ulrike; Zaremba, Anne; Thielmann, Carl Maximilian; Ugurel, Selma; Zimmer, Lisa; Hadaschik, Eva; Bechrakis, Nikolaos E.; Schadendorf, Dirk; Westekemper, Henrike; Livingstone, Elisabeth; Griewank, Klaus G.; German Dermatologic Cooperative Oncology Group (DeCOG, committee ocular melanoma)
    Genetic characterization of advanced conjunctival melanoma and response to systemic treatment
    In: European Journal of Cancer (EJC), Jg. 166, 2022, S. 60 – 72
    DOI
  • Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike; Helfrich, Iris; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne; Ugurel, Selma
    Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer, Jg. 10, 2022, Nr. 6, e004509
    DOI (Open Access)
  • Elsayad, Khaled; Rolf, Daniel; Sunderkötter, Cord; Weishaupt, Carsten; Müller, Elisa Christina; Nawar, Tarek; Stranzenbach, Rene; Livingstone, Elisabeth; Stadler, Rudolf; Steinbrink, Kerstin; Moritz, Rose K. C.; Eich, Hans Theodor
    Low‐dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T‐cell lymphoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 20, 2022, Nr. 3, S. 279 – 285
    DOI (Open Access)
  • Jansen, Philipp; Lodde, Georg; Griewank, Klaus; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk
    Management of partial and non-responding cutaneous squamous cell carcinoma
    In: Journal of the European Academy of Dermatology and Venereology, Jg. 36, 2022, Nr. S1, S. 29 – 34
    DOI (Open Access)
  • Ferdinandus, Justin; Zaremba-Montenari, Anne; Zimmer, Lisa; Umutlu, Lale; Seifert, Robert; Barbato, Francesco; Ugurel, Selma; Chorti, Eleftheria; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
    In: Cancer Imaging, Jg. 22, 2022, Nr. 1
    DOI, Online Volltext (Open Access)
  • Elsayad, Khaled; Rolf, Daniel; Sunderkötter, Cord; Weishaupt, Carsten; Müller, Elisa Christina; Nawar, Tarek; Stranzenbach, Rene; Livingstone, Elisabeth; Stadler, Rudolf; Steinbrink, Kerstin; Moritz, Rose K. C.; Eich, Hans Theodor
    Niedrig dosierte Ganzhautelektronenbestrahlung mit oraler Bexaroten-Erhaltungstherapie beim kutanen T-Zell-Lymphom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 20, 2022, Nr. 3, S. 279 – 286
    DOI (Open Access)
  • Nawar, Tarek; Elsayad, Khaled; Müller, Elisa Christina; Rolf, Daniel; Moritz, Rose K.C.; Bormann, Eike; Weishaupt, Carsten; Stranzenbach, René; Stadler, Rudolf; Moustakis, Christos; Assaf, Chalid; Livingstone, Elisabeth; Sunderkötter, Cord; Steinbrink, Kerstin; Eich, Hans Theodor
    Quality of life in patients with mycosis fungoides and Sézary syndrome undergoing low-dose total skin electron beam therapy with or without maintenance therapy
    In: Journal of the American Academy of Dermatology: JAAD, Jg. 86, 2022, Nr. 4, S. 889 – 891
    DOI (Open Access)
  • Ferdinandus, Justin; Fendler, Wolfgang; Lückerath, Katharina; Berliner, Christoph; Kurzidem, Sabine; Hadaschik, Eva; Klode, Joachim; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Herrmann, Ken; Becker, Jürgen; Ugurel, Selma
    Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
    In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 3, S. 396 – 398
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Matull, Johanna; Zaremba, Anne; Murali, Rajmohan; Chorti, Eleftheria; Lodde, Georg; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus G.
    TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
    In: European Journal of Cancer (EJC), Jg. 161, 2022, S. 99 – 107
    DOI, Online Volltext (Open Access)
  • Michel, Lars; Helfrich, Iris; Hendgen-Cotta, Ulrike Barbara; Mincu, Raluca-Ileana; Korste, Sebastian; Mrotzek, Simone Maria; Spomer, Armin; Odersky, Andrea; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Coman, Cristina; Ahrends, Robert; Sickmann, Albert; Löffek, Stefanie; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Gunzer, Matthias; Schadendorf, Dirk; Totzeck, Matthias; Rassaf, Tienush
    Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
    In: European Heart Journal, Jg. 43, 2022, Nr. 4, S. 316 – 329
    DOI
  • Hegedüs, Luca; Livingstone, Elisabeth; Bankfalvi, Agnes; Viehof, Jan; Enyedi, Ágnes; Bilecz, Ágnes; Győrffy, Balázs; Baranyi, Marcell; Tőkés, Anna-Mária; Gil, Jeovanis; Marko-Varga, György; Griewank, Klaus; Zimmer, Lisa; Váraljai, Renáta; Sucker, Antje; Zaremba, Anne; Schadendorf, Dirk; Aigner, Clemens; Hegedüs, Balázs
    The Prognostic Relevance of PMCA4 Expression in Melanoma : Gender Specificity and Implications for Immune Checkpoint Inhibition
    In: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 6, 3324
    DOI, Online Volltext (Open Access)
  • Sauter, Daniel; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, Markus
    Validating Automatic Concept-Based Explanations for AI-Based Digital Histopathology
    In: Sensors, Jg. 22, 2022, Nr. 14, 5346
    DOI, Online Volltext (Open Access)
  • Hegedüs, Luca; Okumus, Özlem; Livingstone, Elisabeth; Baranyi, Marcell; Kovács, Ildikó; Döme, Balázs; Tóvári, József; Bankfalvi, Agnes; Schadendorf, Dirk; Aigner, Clemens; Hegedüs, Balázs
    Allosteric and ATP-competitive MEK-inhibition in a novel spitzoid melanoma model with a raf-and phosphorylation-independent mutation
    In: Cancers, Jg. 13, 2021, Nr. 4, S. 829
    DOI, Online Volltext (Open Access)
  • Placke, Jan-Malte; Rawitzer, Josefine; Reis, Henning; Rashidi-Alavijeh, Jassin; Livingstone, Elisabeth; Ugurel, Selma; Hadaschik, Eva; Griewank, Klaus; Schmid, Kurt Werner; Schadendorf, Dirk; Rösch, Alexander; Zimmer, Lisa
    Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition : Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry
    In: Frontiers in Oncology, Jg. 11, 2021, 725549
    DOI, Online Volltext (Open Access)
  • Schmidt, Teresa; Kebir, Sied; Livingstone, Elisabeth; Junker, Andreas; Zülow, Stefan; Lazaridis, Lazaros; Oster, Christoph; Chorti, Eleftheria; Pierscianek, Daniela; Pul, Refik; Keyvani, Kathy; Sure, Ulrich; Stuschke, Martin; Kleinschnitz, Christoph; Scheffler, Björn; Zimmer, Lisa; Glas, Martin
    Case Report : Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma
    In: Frontiers in Oncology, Jg. 11, 2021, S. 637185
    DOI, Online Volltext (Open Access)
  • Zaremba, Anne; Philip, Manuel; Hassel, Jessica C.; Glutsch, Valerie; Fiocco, Zeno; Loquai, Carmen; Rafei-Shamsabadi, David; Gutzmer, Ralf; Utikal, Jochen; Haferkamp, Sebastian; Reinhardt, Lydia; Kähler, Katharina C.; Weishaupt, Carsten; Moreira, Alvaro; Thoms, Kai-Martin; Wilhelm, Tabea; Pföhler, Claudia; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Stadtler, Nadine; Sucker, Antje; Kiecker, Felix; Heinzerling, Lucie; Meier, Friedegund; Meiss, Frank; Schlaak, Max; Schilling, Bastian; Horn, Susanne; Schadendorf, Dirk; Livingstone, Elisabeth
    Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
    In: European Journal of Cancer (EJC), Jg. 152, 2021, S. 139 – 154
    DOI
  • Franklin, Cindy; Wetter, Axel; Baba, Hideo Andreas; Theysohn, Jens; Haubold, Johannes; Cosgarea, Ioana; Hadaschik, Eva; Livingstone, Elisabeth; Zimmer, Lisa; Stoffels, Ingo; Klode, Joachim; Lodde, Georg; Placke, Jan-Malte; Schadendorf, Dirk; Ugurel, Selma
    Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer : A retrospective analysis of 47 cases
    In: European Journal of Cancer (EJC), Jg. 150, 2021, S. 119 – 129
    DOI
  • Bolz, Saskia; Ramakrishnan, Thivyah; Fleischer, Michael; Livingstone, Elisabeth; Stolte, Benjamin; Thimm, Andreas; Kizina, Kathrin; Ugurel, Selma; Kleinschnitz, Christoph; Glas, Martin; Zimmer, Lisa; Hagenacker, Tim
    Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy
    In: eNeurologicalSci, Jg. 22, 2021, 100324
    DOI (Open Access)
  • Placke, Jan-Malte; Soun, Camille; Bottek, Jenny; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Pfeiffer, Christiane; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, Antje; Griewank, Klaus; Horn, Susanne; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Engel, Daniel Robert; Ugurel, Selma
    Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic Melanoma
    In: Frontiers in Oncology, Jg. 11, 2021, 741993
    DOI, Online Volltext (Open Access)
  • Stege, Henner; Haist, Maximilian; Schultheis, Michael; Fleischer, Maria Isabel; Mohr, Peter; Meier, Friedegund; Schadendorf, Dirk; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa; Herbst, Rudolf; Pföhler, Claudia; Kähler, Katharina; Weichenthal, Michael; Terheyden, Patrick; Nashan, Dorothée; Debus, Dirk; Kaatz, Martin; Ziller, Fabian; Haferkamp, Sebastian; Forschner, Andrea; Leiter, Ulrike; Kreuter, Alexander; Ulrich, Jens; Kleemann, Johannes; Bradfisch, Fabienne; Grabbe, Stephan; Loquai, Carmen
    Discontinuation of braf/mek-directed targeted therapy after complete remission of metastatic melanoma : a retrospective multicenter adoreg study
    In: Cancers, Jg. 13, 2021, Nr. 10, S. 2312
    DOI (Open Access)
  • Zimmer, Lisa; Livingstone, Elisabeth; Krackhardt, Angela; Schultz, Erwin S.; Göppner, Daniela; Assaf, Chalid; Trebing, Dietrich; Stelter, Kai; Windemuth-Kieselbach, Christine; Ugurel, Selma; Schadendorf, Dirk
    Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAFV⁶⁰⁰ mutant melanoma : safety and tolerability results from the phase I IMMU-TARGET trial
    In: European Journal of Cancer (EJC), Jg. 158, 2021, S. 72 – 84
    DOI
  • Lodde, Georg; Forschner, Andrea; Hassel, Jessica; Wulfken, Lena M.; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Schatton, Kerstin; Gebhardt, Christoffer; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Stang, Andreas; Kowall, Bernd; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Factors influencing the adjuvant therapy decision : Results of a real-world multicenter data analysis of 904 melanoma patients
    In: Cancers, Jg. 13, 2021, Nr. 10, S. 2319
    DOI, Online Volltext (Open Access)
  • Hassel, Jessica Cecile; Livingstone, Elisabeth; Allam, Jean Pierre; Behre, Hermann M.; Bojunga, Jörg; Klein, Horst Harald; Landsberg, Jennifer; Nawroth, Frank; Schüring, Andreas N.; Susok, Laura; Thoms, Kai Martin; Kiesel, Ludwig; Berking, Carola
    Fertility preservation and management of pregnancy in melanoma patients requiring systemic therapy
    In: ESMO Open, Jg. 6, 2021, Nr. 5, 100248
    DOI (Open Access)
  • Zaremba, Anne; Kramer, Rafaela; De Temple, Viola; Bertram, Stefanie; Salzmann, Martin; Gesierich, Anja; Reinhardt, Lydia; Baroudjian, Barouyr; Sachse, Michael M.; Mechtersheimer, Gunhild; Johnson, Douglas B.; Weppler, Alison M.; Spain, Lavinia; Loquai, Carmen; Dudda, Milena; Pföhler, Claudia; Hepner, Adriana; Long, Georgina V.; Menzies, Alexander M.; Carlino, Matteo S.; Lebbé, Céleste; Enokida, Tomohiro; Tahara, Makoto; Bröckelmann, Paul J.; Eigentler, Thomas; Kähler, Katharina C.; Gutzmer, Ralf; Berking, Carola; Ugurel, Selma; Stadtler, Nadine; Sucker, Antje; Becker, Jürgen; Livingstone, Elisabeth; Meier, Friedegund; Hassel, Jessica C.; Schadendorf, Dirk; Hanoun, Maher; Heinzerling, Lucie; Zimmer, Lisa
    Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition : A Descriptive Observational Retrospective Multicenter Analysis
    In: Frontiers in Oncology, Jg. 11, 2021, 765608
    DOI, Online Volltext (Open Access)
  • Albrecht, Margarete; Hadaschik, Eva; Zimmer, Lisa; Livingstone, Elisabeth; Hamacher, Rainer; Bauer, Sebastian; Schadendorf, Dirk; Ugurel, Selma
    Kutanes Angiosarkom mit klinischem Bild eines Quincke-Ödems
    In: Der Hautarzt, Jg. 72, 2021, Nr. 9, S. 801 – 804
    DOI (Open Access)
  • Chorti, Eleftheria; Kebir, Sied; Ahmed, Misbah S.; Keyvani, Kathy; Umutlu, Lale; Kanaki, Theodora; Zaremba, Anne; Reinboldt-Jockenhöfer, Finja; Knispel, Sarah; Gratsias, Emmanouil; Rösch, Alexander; Ugurel, Selma; Scheffler, Björn; Schadendorf, Dirk; Livingstone, Elisabeth; Meier, Friedegund; Glas, Martin; Zimmer, Lisa
    Leptomeningeal disease from melanoma : Poor prognosis despite new therapeutic modalities
    In: European Journal of Cancer (EJC), Jg. 148, 2021, S. 395 – 404
    DOI
  • Elsayad, K.; Nawar, T.; Müller, E.; Rolf, D.; Moritz, R.; Bormann, E.; Weishaupt, C.; Stranzenbach, R.; Stadler, R.; Moustakis, C.; Assaf, C.; Livingstone, Elisabeth; Sunderkoetter, C.; Steinbrink, K.; Eich, H. T.
    Long-term Quality of Life in Patients with Mycosis fungoides and Sezary Syndrome after low-dose Total Skin Electron Irradiation : Prospective Study
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 197, 2021, Nr. Suppl. 1, S. 57 – S58
  • Thielmann, Carl Maximilian; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa; Paredes, Bruno E.; Brinkmeier, Thomas; Griewank, Klaus; Schadendorf, Dirk; Klode, Joachim; Stoffels, Ingo; Hadaschik, Eva
    Metastatic pigmented epithelioid melanocytoma in a 7-year-old female
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 19, 2021, Nr. 8, S. 1217 – 1219
    DOI (Open Access)
  • Zaremba, Anne; Lodde, Georg; Murali, Rajmohan; Philip, Manuel; Cosgarea, Ioana; Jansen, Philipp; Chorti, Eleftheria; Rose, Christian; Hemmerlein, Bernhard; Matull, Johanna; Thielmann, Carl Maximilian; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Horn, Susanne; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus
    Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
    In: European Journal of Cancer (EJC), Jg. 148, 2021, S. 340 – 347
    DOI, Online Volltext (Open Access)
  • Thielmann, Carl Maximilian; Chorti, Eleftheria; Matull, Johanna; Murali, Rajmohan; Zaremba-Montenari, Anne; Lodde, Georg; Jansen, Philipp; Richter, Luisa; Kretz, Julia; Möller, Inga; Sucker, Antje; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Hadaschik, Eva; Ugurel, Selma; Griewank, Klaus
    NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
    In: European Journal of Cancer (EJC), Jg. 159, 2021, S. 113 – 124
    DOI
  • Knispel, Sarah; Gassenmaier, Maximilian; Menzies, Alexander M.; Loquai, Carmen; Johnson, Douglas B.; Franklin, Cindy; Gutzmer, Ralf; Hassel, Jessica C.; Weishaupt, Carsten; Eigentler, Thomas; Schilling, Bastian; Schummer, Patrick; Sirokay, Judith; Kiecker, Felix; Owen, Carina N.; Fleischer, Maria I.; Cann, Christopher; Kähler, Katharina C.; Mohr, Peter; Bluhm, Leonie; Niebel, Dennis; Thoms, Kai-Martin; Goldinger, Simone M.; Reinhardt, Lydia; Meier, Friedegund; Berking, Carola; Reinhard, Raphael; Susok, Laura; Ascierto, Paolo A.; Drexler, Konstantin; Pföhler, Claudia; Tietze, Julia; Heinzerling, Lucie; Livingstone, Elisabeth; Ugurel, Selma; Long, Georgina V.; Stang, Andreas; Schadendorf, Dirk; Zimmer, Lisa
    Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition
    In: European Journal of Cancer (EJC), Jg. 148, 2021, S. 61 – 75
    DOI
  • Steeb, Theresa; Wessely, Anja; Alter, Mareike; Bayerl, Christiane; Bender, Armin; Bruning, Guido; Dabrowski, Evelyn; Debus, Dirk; Devereux, Nina; Dippel, Edgar; Drexler, Konstantin; Dücker, Pia; Dummer, Reinhard; Emmert, Steffen; Elsner, Peter; Enk, Alexander; Gebhardt, Christoffer; Gesierich, Anja; Goebeler, Matthias; Goerdt, Sergij; Goetze, Steven; Gutzmer, Ralf; Haferkamp, Sebastian; Hansel, Gesina; Hassel, Jessica C.; Heinzerling, Lucie; Kähler, Katharina C.; Kaume, Kjell M.; Krapf, Wolfgang; Kreuzberg, Nicole; Lehmann, Percy; Livingstone, Elisabeth; Löffler, Harald; Loquai, Carmen; Mauch, Cornelia; Mangana, Johanna; Meier, Friedegund; Meissner, Markus; Moritz, Rose K. C.; Maul, Lara Valeska; Müller, Verena; Mohr, Peter; Navarini, Alexander; Van Nguyen, Ahn; Pfeiffer, Christiane; Pföhler, Claudia; Posch, Christian; Richtig, Erika; Rompel, Rainer; Sachse, Michael M.; Sauder, Stefanie; Schadendorf, Dirk; Schatton, Kerstin; Schulze, Hans-Joachim; Schultz, Erwin; Schilling, Bastian; Schmuth, Matthias; Simon, Jan. C.; Streit, Markus; Terheyden, Patrick; Thiem, Alexander; Tüting, Thomas; Welzel, Julia; Weyandt, Gerhard; Wesselmann, Ulrich; Wollina, Uwe; Ziemer, Mirjana; Zimmer, Lisa; Zutt, Markus; Berking, Carola; Schlaak, Max; Heppt, Markus V.
    Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries : A multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)
    In: Journal of Cancer Research and Clinical Oncology, Jg. 147, 2021, Nr. 6, S. 1763 – 1771
    DOI (Open Access)
  • Brase, Jan C.; Walter, Robert F.H.; Savchenko, Alexander; Gusenleitner, Daniel; Garrett, James; Schimming, Tobias; Varaljai, Renata; Castelletti, Deborah; Kim, Ju; Dakappagari, Naveen; Schultz, Ken; Robert, Caroline; Long, Georgina V.; Nathan, Paul D.; Ribas, Antoni; Flaherty, Keith T.; Karaszewska, Boguslawa; Schachter, Jacob; Sucker, Antje; Schmid, Kurt Werner; Zimmer, Lisa; Livingstone, Elisabeth; Gasal, Eduard; Schadendorf, Dirk; Rösch, Alexander
    Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
    In: Clinical Cancer Research, Jg. 27, 2021, Nr. 16, S. 4500 – 4510
    DOI (Open Access)
  • Wessely, Anja; Steeb, Theresa; Berking, Carola; Schlaak, Max; Heppt, Markus V.; Alter, Mareike; Bayerl, Christiane; Bender, Armin; Bruning, Guido; Dabrowski, Evelyn; Debus, Dirk; Devereux, Nina; Dippel, Edgar; Drexler, Konstantin; Dücker, Pia; Dummer, Reinhard; Emmert, Steffen; Elsner, Peter; Enk, Alexander; Gebhardt, Christoffer; Gesierich, Anja; Goebeler, Matthias; Goerdt, Sergij; Goetze, Steven; Gutzmer, Ralf; Haferkamp, Sebastian; Hansel, Gesina; Hassel, Jessica C.; Heinzerling, Lucie; Kähler, Katharina C.; Kaume, Kjell M.; Krapf, Wolfgang; Kreuzberg, Nicole; Lehmann, Percy; Livingstone, Elisabeth; Löffler, Harald; Loquai, Carmen; Mauch, Cornelia; Mangana, Johanna; Meier, Friedegund; Meissner, Markus; Moritz, Rose K.C.; Maul, Lara Valeska; Müller, Verena; Mohr, Peter; Navarini, Alexander; Van Nguyen, Ahn; Pfeiffer, Christiane; Pföhler, Claudia; Posch, Christian; Richtig, Erika; Rompel, Rainer; Sachse, Michael M.; Sauder, Stefanie; Schadendorf, Dirk; Schatton, Kerstin; Schulze, Hans-Joachim; Schultz, Erwin; Schilling, Bastian; Schmuth, Matthias; Simon, Jan C.; Streit, Markus; Terheyden, Patrick; Thiem, Alexander; Tüting, Thomas; Welzel, Julia; Weyandt, Gerhard; Wesselmann, Ulrich; Wollina, Uwe; Ziemer, Mirjana; Zimmer, Lisa; Zutt, Markus
    Surveillance of patients with conjunctival melanoma in German-speaking countries : A multinational survey of the German dermatologic cooperative oncology group
    In: European Journal of Cancer (EJC), Jg. 143, 2021, S. 43 – 45
    DOI
  • Dimitriou, Florentia; Zaremba, Anne; Allayous, Clara; Kähler, Katharina C.; Gerard, Camille L.; Festino, Lucia; Schäfer, Sarah; Toussaint, Frédéric; Heinzerling, Lucie; Hassel, Jessica C.; Ascierto, Paolo A.; Michielin, Olivier; Hauschild, Axel; Lebbe, Céleste; Livingstone, Elisabeth; Ramelyte, Egle; Cheng, Phil F.; Dummer, Reinhard; Mangana, Joanna
    Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response
    In: European Journal of Cancer (EJC), Jg. 149, 2021, S. 37 – 48
    DOI (Open Access)
  • Zaremba, Anne; Eggermont, Alexander M.M.; Robert, Caroline; Dummer, Reinhardt; Ugurel, Selma; Livingstone, Elisabeth; Ascierto, Paolo A.; Long, Georgina V.; Schadendorf, Dirk; Zimmer, Lisa
    The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients
    In: European Journal of Cancer (EJC), Jg. 155, 2021, S. 268 – 280
    DOI
  • Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel, Edgar; Rösch, Alexander; Simon, Jan-Christoph; Conrad, Beate; Körner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Jürgen C.; Schadendorf, Dirk; Berking, Carola; Herbst, Rudolf A.; Martens, Uwe M; Sell, Sabine; Stadler, Rudolf; Terheyden, Patrick; Utikal, Jochen
    Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : A randomised, double-blind, placebo-controlled, phase 2 trial
    In: Lancet, Jg. 395, 2020, Nr. 10236, S. 1558 – 1568
    DOI
  • Liu, David; Schilling, Bastian; Liu, Derek; Sucker, Antje; Livingstone, Elisabeth; Jerby-Arnon, Livnat; Zimmer, Lisa; Gutzmer, Ralf; Satzger, Imke; Loquai, Carmen; Grabbe, Stephan; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Gogas, Helen; Goldinger, Simone M.; Utikal, Jochen; Blank, Christian U.; Rauschenberg, Ricarda; von Bubnoff, Dagmar; Krackhardt, Angela; Weide, Benjamin; Haferkamp, Sebastian; Kiecker, Felix; Izar, Ben; Garraway, Levi; Regev, Aviv; Flaherty, Keith; Paschen, Annette; Van Allen, Eliezer M.; Schadendorf, Dirk
    Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
    In: Nature Medicine, Jg. 26, 2020, Nr. 7, S. 1147
    DOI (Open Access)
  • Chorti, Eleftheria; Kanaki, Theodora; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Gratsias, Emmanouil; Rösch, Alexander; Bonella, Francesco; Wessendorf, Thomas; Wälscher, Julia; Theegarten, Dirk; Schadendorf, Dirk; Livingstone, Elisabeth
    Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy : Increased rate and mimicker of metastasis
    In: European Journal of Cancer (EJC), Jg. 131, 2020, S. 18 – 26
    DOI
  • Matull, Johanna; Livingstone, Elisabeth; Wetter, Axel; Zimmer, Lisa; Zaremba, Anne; Lahner, Harald; Schadendorf, Dirk; Ugurel, Selma
    Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade : A Case Report
    In: Frontiers in Oncology, Jg. 10, 2020, S. 592609
    DOI, Online Volltext (Open Access)
  • Pohl, Julia; Mincu, Raluca-Ileana; Mrotzek, Simone Maria; Hinrichs, Lena; Michel, Lars; Livingstone, Elisabeth; Zimmer, Lisa; Wakili, Reza; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias
    ECG Changes in Melanoma Patients Undergoing Cancer Therapy : Data from the ECoR Registry
    In: Journal of Clinical Medicine (JCM), Jg. 9, 2020, Nr. 7, 2060
    DOI, Online Volltext (Open Access)
  • Ugurel, Selma; Schadendorf, Dirk; Horny, K.; Sucker, Antje; Schramm, Sabine; Utikal, Jochen; Pföhler, Claudia; Herbst, Rudolf A.; Schilling, B.; Blank, Christian U.; Becker, Jürgen; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Peter; Rebmann, Vera
    Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
    In: Annals of Oncology, Jg. 31, 2020, Nr. 1, S. 144 – 152
    DOI (Open Access)
  • Zaremba, Anne; Zimmer, Lisa; Chorti, Eleftheria; Reissig, Timm M.; Bauer, Sebastian; Podleska, Lars; Schulz, Andrea; Hadaschik, Eva; Griewank, Klaus; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Fatal swelling of the groin – Clear cell sarcoma : A rare but important differential diagnosis to malignant melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 18, 2020, Nr. 10, S. 1165 – 1168
    DOI (Open Access)
  • Livingstone, Elisabeth; Zaremba, Anne; Horn, Susanne; Ugurel, Selma; Casalini, Belén; Schlaak, Max; Hassel, Jessica Cecile; Herbst, Rudolf A.; Utikal, Jochen; Weide, Benjamin M.; Gutzmer, Ralf; Meier, Friedegund E.; Koelsche, Christian; Hadaschik, Eva; Sucker, Antje; Reis, Henning; Merkelbach-Bruse, Sabine; Siewert, Martina M.; Sahm, Felix; von Deimling, Andreas; Cosgarea, Ioana; Zimmer, Lisa; Schadendorf, Dirk; Schilling, Bastian; Griewank, Klaus
    GNAQ and GNA11 mutant nonuveal melanoma : A subtype distinct from both cutaneous and uveal melanoma
    In: British Journal of Dermatology: BJD, Jg. 183, 2020, Nr. 5, S. 928 – 939
    DOI (Open Access)
  • Leiter, Ulrike; Loquai, Carmen; Reinhardt, Lydia; Rafei-Shamsabadi, David; Gutzmer, Ralf; Kaehler, Katharina; Heinzerling, Lucie; Hassel, Jessica C.; Glutsch, Valerie; Sirokay, Judith; Schlecht, Nora; Rübben, Albert; Gambichler, Thilo; Schatton, Kerstin; Pfoehler, Claudia; Franklin, Cindy; Terheyden, Patrick; Haferkamp, Sebastian; Mohr, Peter; Bischof, Lena; Livingstone, Elisabeth; Zimmer, Lisa; Weichenthal, Michael; Schadendorf, Dirk; Meiwes, Andreas; Keim, Ulrike; Garbe, Claus; Becker, Jürgen; Ugurel, Selma
    Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy : A retrospective multicenter DeCOG study of 84 patients
    In: Journal for ImmunoTherapy of Cancer, Jg. 8, 2020, Nr. 2, S. e000897
    DOI (Open Access)
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Immuntherapie beim malignen Melanom
    In: Der Internist, Jg. 61, 2020, Nr. 7, S. 669 – 675
    DOI (Open Access)
  • Knispel, Sarah; Stang, Andreas; Zimmer, Lisa; Lax, Hildegard; Gutzmer, Ralf; Heinzerling, Lucie; Weishaupt, Carsten; Pföhler, Claudia; Gesierich, Anja; Herbst, Rudolf; Kaehler, Katharina C.; Weide, Benjamin; Berking, Carola; Loquai, Carmen; Utikal, Jochen; Terheyden, Patrick; Kaatz, Martin; Schlaak, Max; Kreuter, Alexander; Ulrich, Jens; Mohr, Peter; Dippel, Edgar; Livingstone, Elisabeth; Becker, Jürgen; Weichenthal, Michael; Chorti, Eleftheria; Gronewold, Janine; Schadendorf, Dirk; Ugurel, Selma
    Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma : A multicenter retrospective cohort study of the DeCOG
    In: Journal for ImmunoTherapy of Cancer, Jg. 8, 2020, Nr. 1, S. e000395
    DOI (Open Access)
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Hautarzt, Jg. 71, 2020, S. 63 – 77
    DOI
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Pathologe, Jg. 41, 2020, Nr. 3, S. 281 – 292
    DOI
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Onkologe, Jg. 26, 2020, Nr. 1, S. 75 – 87
    DOI
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Malignes Melanom : Stellenwert der BRAF-Inhibition beim malignen Melanom
    In: Der Onkologe, Jg. 26, 2020, Nr. 8, S. 713 – 720
    DOI
  • Ugurel, Selma; Röhmel, Joachim; Ascierto, Paolo A.; Becker, Jürgen C.; Flaherty, Keith T.; Grob, Jean J.; Hauschild, Axel; Larkin, James; Livingstone, Elisabeth; Long, Georgina V.; Lorigan, Paul; McArthur, Grant A.; Ribas, Antoni; Robert, Caroline; Zimmer, Lisa; Schadendorf, Dirk; Garbe, Claus
    Survival of patients with advanced metastatic melanoma : The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
    In: European Journal of Cancer (EJC), Jg. 130, 2020, S. 126 – 138
    DOI
  • Matsuya, Taisuke; Nakamura, Yasuhiro; Matsushita, Shigeto; Tanaka, Ryota; Teramoto, Yukiko; Asami, Yuri; Uehara, Jiro; Aoki, Megumi; Yamamura, Kentaro; Nakamura, Yoshiyuki; Fujisawa, Yasuhiro; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Kagamu, Hiroshi; Fujimoto, Manabu; Honma, Masaru; Ishida-Yamamoto, Akemi; Araki, Ryuichiro; Yamamoto, Akifumi
    Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma : A multi-institutional retrospective study
    In: The Journal of Dermatology, Jg. 47, 2020, Nr. 6, S. 629 – 635
    DOI
  • Zaremba, Anne; Murali, Rajmohan; Jansen, Philipp; Möller, Inga; Sucker, Antje; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Brinker, Titus J.; Hadaschik, Eva; Franklin, Cindy; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus; Cosgarea, Ioana
    Clinical and genetic analysis of melanomas arising in acral sites
    In: European Journal of Cancer (EJC), Jg. 119, 2019, S. 66 – 76
    DOI (Open Access)
  • Drago, Joshua Z.; Lawrence, Donald; Livingstone, Elisabeth; Zimmer, Lisa; Chen, Tianqi; Giobbie-Hurder, Anita; Amann, Valerie C.; Mangana, Joanna; Siano, Marco; Zippelius, Alfred; Dummer, Reinhard; Goldinger, Simone M.; Sullivan, Ryan J.
    Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases : a real-life multicenter study
    In: Melanoma Research, Jg. 29, 2019, Nr. 1, S. 65 – 69
    DOI (Open Access)
  • Livingstone, Elisabeth
    Evaluation of cutaneous adverse events of encorafenib and binimetinb : COMMENT on article by Graf et al.
    In: Journal of the European Academy of Dermatology and Venereology, Jg. 33, 2019, Nr. 4, S. 630 – 631
    DOI (Open Access)
  • Schilling, Bastian; Martens, Alexander; Geukes Foppen, Marnix H.; Gebhardt, Christoffer; Hassel, Jessica C.; Rozeman, Elisa A.; Gesierich, Anja; Gutzmer, Ralf; Kähler, Katharina C.; Livingstone, Elisabeth; Diamantopoulos, Panagiotis T.; Gogas, Helen; Madonna, Gabriele; Ascierto, Paolo A.; Goldinger, Simone M.; Mangana, Johanna; Garbe, Claus; Schadendorf, Dirk; Blank, Christian; Weide, Benjamin
    First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis
    In: Cancer Immunology, Immunotherapy, Jg. 68, 2019, Nr. 5, S. 765 – 772
    DOI, Online Volltext (Open Access)
  • Ugurel, Selma; Schadendorf, Dirk; Sucker, A.; Schramm, Sara; Utikal, J.; Pfohler, C.; Herbst, R.; Schilling, Bastian; Blank, C.; Becker, J. C.; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Peter; Rebmann, Vera
    High PD-1 or PD-L1 Concentrations in the Serum of Melanoma Patients are predictive for reduced Therapeutic Success of PD-1 Inhibition
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 17, 2019, Nr. Suppl. 5, S. 7 – 7
  • Kanaki, Theodora; Stang, Andreas; Gutzmer, Ralf; Zimmer, Lisa; Chorti, Eleftheria; Sucker, Antje; Ugurel, Selma; Hadaschik, Eva; Gräger, Nikolai S.; Satzger, Imke; Schadendorf, Dirk; Livingstone, Elisabeth
    Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma
    In: European Journal of Cancer (EJC), Jg. 119, 2019, S. 18 – 29
    DOI
  • Liu, David; Schilling, Bastian; Liu, Derek; Sucker, Antje; Livingstone, Elisabeth; Jerby-Amon, Livnat; Zimmer, Lisa; Gutzmer, Ralf; Satzger, Imke; Loquai, Carmen; Grabbe, Stephan; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Gogas, Helen; Goldinger, Simone M.; Utikal, Jochen; Blank, Christian U.; Rauschenberg, Ricarda; Bubnoff, Dagmar von; Krackhardt, Angela; Weide, Benjamin; Haferkamp, Sebastian; Kiecker, Felix; Izar, Ben; Garraway, Levi; Regev, Aviv; Flaherty, Keith; Paschen, Annette; Allen, Eliezer M. van; Schadendorf, Dirk
    Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
    In: Nature Medicine, Jg. 25, 2019, Nr. 12, S. 1916 – 1927
    DOI (Open Access)
  • Zaremba, Anne; Chorti, Eleftheria; Jockenhöfer, Finja; Bolz, Saskia; Sirin, Selma; Glas, Martin; Becker, Jürgen C.; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth; Hagenacker, Tim; Zimmer, Lisa
    Metastatic Merkel cell carcinoma and myasthenia gravis : contraindication for therapy with immune checkpoint inhibitors?
    In: Journal for ImmunoTherapy of Cancer, Jg. 7, 2019, Nr. 1, S. 141
    DOI, Online Volltext (Open Access)
  • Viehof, Jan; Livingstone, Elisabeth; Loscha, Elena; Stockhammer, Paul; Bankfalvi, Agnes; Plönes, Till; Mardanzai, Khaled; Zimmer, Lisa; Sucker, Antje; Schadendorf, Dirk; Hegedüs, Balazs; Aigner, Clemens
    Prognostic factors for pulmonary metastasectomy in malignant melanoma : Size matters
    In: European Journal of Cardio-Thoracic Surgery, Jg. 56, 2019, Nr. 6, S. 1104 – 1109
    DOI (Open Access)
  • Shannan, B.; Matschke, Johann; Chauvistré, Heike; Vogel, F.; Klein, Diana; Meier, Friedegund; Westphal, Dana; Bruns, Johannes; Rauschenberg, Ricarda; Utikal, Jochen; Forschner, Andrea; Berking, Carola; Terheyden, Patrick; Dabrowski, Evelyn; Gutzmer, Ralf; Rafei-Shamsabadi, David Ali; Meiss, Frank; Heinzerling, Lucie M.; Zimmer, Lisa; Livingstone, Elisabeth; Váraljai, Renáta; Hoewner, A.; Horn, Susanne; Klode, Joachim; Stuschke, Martin; Scheffler, Björn; Marchetto, Aruna; Sannino, Giuseppina; Grünewald, Thomas Georg Philipp; Schadendorf, Dirk; Jendrossek, Verena; Rösch, Alexander
    Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV⁶⁰⁰E inhibition in melanoma
    In: European Journal of Cancer (EJC), Jg. 109, 2019, S. 137 – 153
    DOI
  • Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Treatment in metastatic melanoma : Time to re-think
    In: Annals of Oncology, Jg. 30, 2019, Nr. 4, S. 501 – 503
    DOI (Open Access)
  • Hillen, Uwe; Leiter, Ulrike; Haase, Sylvie; Kaufmann, Roland; Becker, Jürgen; Gutzmer, Ralf; Terheyden, Patrick; Krause-Bergmann, Albrecht; Schulze, Hans-Joachim; Hassel, Jessica; Lahner, Nina; Wollina, Uwe; Ziller, Fabian; Utikal, Jochen; Hafner, Christine; Ulrich, Jens; Machens, Hans-Günther; Weishaupt, Carsten; Hauschild, Axel; Mohr, Peter; Pföhler, Claudia; Maurer, Jan; Wolff, Patrick; Windemuth-Kieselbach, Christine; Schadendorf, Dirk; Livingstone, Elisabeth; Dermatologic Cooperative Oncology Group (DeCOG)
    Advanced cutaneous squamous cell carcinoma : A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG
    In: European Journal of Cancer (EJC), Jg. 96, 2018, S. 34 – 43
    DOI
  • Valpione, Sara; Carlino, Matteo S.; Mangana, Johanna; Mooradian, Meghan J.; McArthur, Grant; Schadendorf, Dirk; Hauschild, Axel; Menzies, Alexander M.; Arance, Ana; Ascierto, Paolo A.; Giacomo, AnnaMaria Di; de Rosa, Francesco; Larkin, James; Park, John J.; Goldinger, Simone M.; Sullivan, Ryan J.; Xu, Wen; Livingstone, Elisabeth; Weichenthal, Michael; Rai, Rajat; Gaba, Lydia; Long, Georgina V.; Lorigan, Paul
    Corrigendum to “Rechallenge with BRAF-directed treatment in metastatic melanoma : A multi-institutional retrospective study*” [Eur J Cancer 91 (2018) 116–124]
    In: European Journal of Cancer (EJC), Jg. 93, 2018, S. 158
    DOI
  • Olischewsky, Alexandra; De Schrijver, Sofie; Bankfalvi, Agnes; Wetter, Axel; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Dose-dependent toxicity of ipilimumab in metastatic melanoma
    In: European Journal of Cancer (EJC), Jg. 95, 2018, S. 104 – 108
    DOI
  • Wagner, Tobias; Augustin, Matthias; Blome, Christine; Forschner, Andrea; Garbe, Claus; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Schadendorf, Dirk; Terheyden, Patrick; Mueller-Brenne, Tina; Kähler, Katharina C.
    Fear of cancer progression in patients with stage IA malignant melanoma
    In: European Journal of Cancer Care, Jg. 27, 2018, Nr. 5, e12901
    DOI
  • Milsch, Laura; Gesierich, Anja; Kreft, Sophia; Livingstone, Elisabeth; Zimmer, Lisa; Goebeler, Matthias; Schadendorf, Dirk; Schilling, Bastian
    Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade
    In: European Journal of Cancer (EJC), Jg. 99, 2018, S. 58 – 65
    DOI
  • Krajewski, Christin; Benson, Sven; Elsenbruch-Harnish, Sigrid; Schadendorf, Dirk; Livingstone, Elisabeth
    Predictors of quality of life in melanoma patients 4 years after diagnosis : Results of a nationwide cohort study in Germany
    In: Journal of Psychosocial Oncology, Jg. 36, 2018, Nr. 6, S. 734 – 753
    DOI
  • Valpione, Sara; Carlino, Matteo S.; Mangana, Johanna; Mooradian, Meghan J.; McArthur, Grant; Schadendorf, Dirk; Hauschild, Axel; Menzies, Alexander M.; Arance, Ana; Ascierto, Paolo A.; Di Giacomo, AnnaMaria; de Rosa, Francesco; Larkin, James; Park, John J.; Goldinger, Simone M.; Sullivan, Ryan J.; Xu, Wen; Livingstone, Elisabeth; Weichenthal, Michael; Rai, Rajat; Gaba, Lydia; Long, Georgina V.; Lorigan, Paul
    Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
    In: European Journal of Cancer (EJC), Jg. 91, 2018, S. 116 – 124
    DOI (Open Access)
  • Jockenhöfer, Finja; Schimming, Tobias T.; Schaller, Jörg; Moege, Jürgen; Livingstone, Elisabeth; Salva, Katrin A.; Zimmer, Lisa; Schadendorf, Dirk; Rösch, Alexander
    Sebaceous tumours: more than skin deep
    In: Gut, Jg. 67, 2018, Nr. 11, S. 2045 – 2053
    DOI
  • Kähler, Katharina C.; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Müller-Brenne, Tina; Schadendorf, Dirk; Utikal, Jochen; Wagner, Tobias; Augustin, Matthias
    The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy : A survey in German melanoma patients and their treating physicians
    In: OncoTarget, Jg. 9, 2018, Nr. 40, S. 26217 – 26225
    DOI (Open Access)
  • Knispel, Sarah; Zimmer, Lisa; Kanaki, Theodora; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth
    The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma
    In: Expert Opinion on Drug Safety, Jg. 17, 2018, Nr. 1, S. 73 – 87
    DOI
  • Augustin, Matthias; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Schadendorf, Dirk; Utikal, Jochen; Wagner, Tobias; Wilden, Sophia; Kähler, Katharina C.
    Willingness to pay for a cure of low-risk melanoma patients in Germany
    In: PLoS ONE, Jg. 13, 2018, Nr. 5, S. e0197780
    DOI (Open Access)
  • Franklin, Cindy; Rooms, Isabelle; Fiedler, Melanie; Reis, Henning; Milsch, Laura; Herz, Saskia; Livingstone, Elisabeth; Zimmer, Lisa; Schmid, Kurt Werner; Dittmer, Ulf; Schadendorf, Dirk; Schilling, Bastian
    Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis
    In: European Journal of Cancer (EJC), Jg. 86, 2017, S. 248 – 256
    DOI
  • Scholz, Simone L.; Möller, Inga; Reis, Henning; Süßkind, Daniela; van de Nes, Johannes; Leonardelli, Sonia; Schilling, Bastian; Livingstone, Elisabeth; Schimming, Tobias; Paschen, Annette; Sucker, Antje; Murali, Rajmohan; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma
    In: Investigative Ophthalmology & Visual Science (IOVS), Jg. 58, 2017, Nr. 9, S. 3464 – 3470
    DOI (Open Access)
  • Ugurel, Selma; Kiecker, Felix; Fröhling, Stefan; Wetter, Axel; Bankfalvi, Agnes; Sucker, Antje; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Becker, Jürgen; Schadendorf, Dirk
    Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma
    In: European Journal of Cancer (EJC), Jg. 83, 2017, S. 142 – 145
    DOI
  • Franklin, Cindy; Livingstone, Elisabeth; Rösch, Alexander; Schilling, Bastian; Schadendorf, Dirk
    Immunotherapy in melanoma : Recent advances and future directions
    In: European Journal of Surgical Oncology, Jg. 43, 2017, Nr. 3, S. 604 – 611
    DOI
  • Delker, Sarah; Livingstone, Elisabeth; Schimming, Tobias; Schadendorf, Dirk; Griewank, Klaus
    Melanoma diagnosed in lesions previously treated by laser therapy
    In: The Journal of Dermatology, Jg. 44, 2017, Nr. 1, S. 23 – 28
    DOI
  • Gutzmer, Ralf; Koop, Anika; Meier, Friedegund; Hassel, Jessica C.; Terheyden, Patrick; Zimmer, Lisa; Heinzerling, Lucie; Ugurel, Selma; Pföhler, Claudia; Gesierich, Anja; Livingstone, Elisabeth; Satzger, Imke; Kähler, Katharina C.
    Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
    In: European Journal of Cancer (EJC), Jg. 75, 2017, S. 24 – 32
    DOI
  • Griewank, Klaus; Müller, Hansgeorg; Jackett, Louise A.; Emberger, Michael; Möller, Inga; van de Nes, Johannes; Zimmer, Lisa; Livingstone, Elisabeth; Wiesner, Thomas; Scholz, Simone L.; Cosgarea, Ioana; Sucker, Antje; Schimming, Tobias; Hillen, Uwe; Schilling, Bastian; Paschen, Annette; Reis, Henning; Mentzel, Thomas; Kutzner, Heinz; Rütten, Arno; Murali, Rajmohan; Scolyer, Richard A.; Schadendorf, Dirk
    SF3B1 and BAP1 mutations in blue nevus-like melanoma
    In: Modern Pathology, Jg. 30, 2017, Nr. 7, S. 928 – 939
    DOI, Online Volltext (Open Access)
  • Cosgarea, Ioana; Ugurel, Selma; Sucker, Antje; Livingstone, Elisabeth; Zimmer, Lisa; Ziemer, Mirjana; Utikal, Jochen; Mohr, Peter; Pfeiffer, Christiane; Pföhler, Claudia; Hillen, Uwe; Horn, Susanne; Schadendorf, Dirk; Griewank, Klaus; Rösch, Alexander
    Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
    In: OncoTarget, Jg. 8, 2017, Nr. 25, S. 40683 – 40692
    DOI (Open Access)
  • Herz, Saskia; Höfer, Thomas; Papapanagiotou, Matina; Leyh, Julia Christina; Meyenburg, Sarah; Schadendorf, Dirk; Ugurel, Selma; Rösch, Alexander; Livingstone, Elisabeth; Schilling, Bastian; Franklin, Cindy
    Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient
    In: European Journal of Cancer (EJC), Jg. 67, 2016, S. 66 – 72
    DOI
  • Fink, Leah; Amelio, Justyna; Harries, Mark; Lebbe, Celeste; Livingstone, Elisabeth; Flinois, Alain
    Making decisions on resectability and injectability status of lesions in the management of advanced melanoma in Germany, France and the UK
    In: European Journal of Dermatology (EJD), Jg. 26, 2016, Nr. 5, S. 477 – 486
    DOI
  • Livingstone, Elisabeth; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Schilling, Bastian
    Medikamentöse Therapie des metastasierten malignen Melanoms
    In: Arzneimitteltherapie (AMT), Jg. 34, 2016, Nr. 1-2, S. 14 – 22
  • Griewank, Klaus; Schilling, Bastian; Scholz, Simone L; Metz, Claudia H; Livingstone, Elisabeth; Sucker, Antje; Möller, Inga; Reis, Henning; Franklin, Cindy; Cosgarea, Ioana; Hillen, Uwe; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Zimmer, Lisa
    Oncogene status as a diagnostic tool in ocular and cutaneous melanoma
    In: European Journal of Cancer (EJC), Jg. 57, 2016, S. 112 – 117
    DOI
  • Kaehler, Katharina C; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Haalck, Thomas; Heinzerling, Lucie; Kornek, Thomas; Livingstone, Elisabeth; Loquai, Carmen; Maul, Lara Valeska; Lang, Berenice M; Schadendorf, Dirk; Stade, Barbara; Terheyden, Patrick; Utikal, Jochen; Wagner, Tobias; Hauschild, Axel; Garbe, Claus; Augustin, Matthias
    Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy
    In: Medicine, Jg. 95, 2016, Nr. 46, S. e5375
    DOI (Open Access)
  • Livingstone, Elisabeth; Eigentler, Thomas Kurt; Windemuth-Kieselbach, Christine; Hauschild, Axel; Rompel, Rainer; Trefzer, Uwe; Nashan, Dorothée; Kilian, Katharina J.; Debus, Dirk; Kähler, Katharina Charlotte; Mauerer, Andreas; Möllenhof, Katrin; Dippel, Edgar; Schadendorf, Dirk
    Actual practice of melanoma follow-up and treatment in Germany : results of a prospective, longitudinal cohort study
    In: British Journal of Dermatology: BJD, Jg. 172, 2015, Nr. 6, S. 1646 – 1650
    DOI
  • Scholz, S.; Horn, S.; Murali, R.; Moeller, I.; Sucker, A.; Sondermann, W.; Stiller, Mathias; Schilling, Bastian; Livingstone, Elisabeth; Zimmer, Lisa; Reis, Henning; Metz, C.; Zeschnigk, Michael; Paschen, Annette; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Analysis of SDHD promoter mutations in various types of melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 13, 2015, Nr. Suppl. 2, S. 11
    DOI
  • Scholz, Simone L.; Horn, Susanne; Murali, Rajmohan; Möller, Inga; Sucker, Antje; Sondermann, Wiebke; Stiller, Mathias; Schilling, Bastian; Livingstone, Elisabeth; Zimmer, Lisa; Reis, Henning; Metz, Claudia H; Zeschnigk, Michael; Paschen, Annette; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Analysis of SDHD promoter mutations in various types of melanoma
    In: OncoTarget, Jg. 6, 2015, Nr. 28, S. 25868 – 25882
    DOI (Open Access)
  • Livingstone, Elisabeth; Swann, Suzanne; Lilla, Carmen; Schadendorf, Dirk; Rösch, Alexander
    Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma
    In: Experimental Dermatology, Jg. 24, 2015, Nr. 9, S. 709 – 710
    DOI
  • Sondermann, Wiebke; Griewank, Klaus; Schilling, Bastian; Livingstone, Elisabeth; Leyh, Julia C.; Rompoti, Natalia; Cosgarae, Ioana; Schimming, Tobias; Schadendorf, Dirk; Zimmer, Lisa; Hillen, Uwe
    Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection
    In: PLoS ONE, Jg. 10, 2015, Nr. 4, S. e0124590
    DOI (Open Access)
  • Zimmer, Lisa; Vaubel, Julia Marianne; Mohr, Peter; Hauschild, Axel; Utikal, Jochen; Simon, Jan; Garbe, Claus; Herbst, Rudolf; Enk, Alexander; Kämpgen, Eckhart; Livingstone, Elisabeth; Bluhm, Leonie; Rompel, Rainer; Griewank, Klaus; Fluck, Michael; Schilling, Bastian; Schadendorf, Dirk
    Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
    In: PLoS ONE, Jg. 10, 2015, Nr. 3, S. e0118564
    DOI (Open Access)
  • Livingstone, Elisabeth; Krajewski, C.; Eigentler, Thomas K.; Windemuth-Kieselbach, Christine; Benson, Sven; Elsenbruch, Sigrid; Hauschild, Axel; Rompel, Rainer; Meiss, Frank; Mauerer, Andreas; Kähler, Katharina C.; Dippel, Edgar; Möllenhoff, Katrin; Kilian, Katharina; Mohr, Mohr, Peter E.; Utikal, Jochen; Schadendorf, Dirk
    Prospective evaluation of follow-up in melanoma patients in Germany : results of a multicentre and longitudinal study
    In: European Journal of Cancer (EJC), Jg. 51, 2015, Nr. 5, S. 653 – 667
    DOI
  • Schilling, Bastian; Sondermann, Wiebke; Griewank, Klaus; Livingstone, Elisabeth; Zimmer, Lisa; Hillen, Uwe; Schadendorf, Dirk
    Reply to the letters to the editor ‘Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma’ by Diwakar et al.
    In: Annals of Oncology, Jg. 26, 2015, Nr. 1, S. 250 – 251
    DOI
  • Livingstone, Elisabeth; Hillen, Uwe; Hafner, Christian; Piel, Sarah; Groesser, Leopold; Schadendorf, Dirk; Happle, Rudolf
    Segmentally arranged seborrhoeic keratoses with impending atypia and squamous cell carcinoma in an elderly woman
    In: British Journal of Dermatology: BJD, Jg. 172, 2015, Nr. 6, S. 1642 – 1645
    DOI
  • Wagner, T.; Terheyden, P.; Gutzmer, R.; Forschner, A.; Rudolph, B.; Schadendorf, Dirk; Kaehler, K.C.; Kornek, T.; Heinzerling, L.; Garbe, C.; Stade, B.; Gebhardt, C.; Augustin, M.; Maul, L.V.; Hauschild, A.; Loquai, C.; Blohme, C.; Livingstone, Elisabeth
    The GERMELATOX DeCOG-trial : The attitude of German melanoma patients towards toxicity during adjuvant interferon treatment - Differences between the patient's and the physician's perspective
    In: European Journal of Cancer (EJC), Jg. 51, 2015, Nr. Suppl. 3, S. S671 – S672
    DOI
  • Schadendorf, Dirk; Livingstone, Elisabeth; Schilling, Bastian; Rösch, Alexander; Zimmer, Lisa
    Therapie des malignen Melanoms
    In: Der Onkologe, Jg. 21, 2015, Nr. 10, S. 965 – 974
    DOI
  • Schilling, Bastian; Sondermann, W.; Zhao, F.; Griewank, Klaus; Livingstone, Elisabeth; Sucker, A.; Zelba, H.; Weide, B.; Trefzer, U.; Wilhelm, T.; Loquai, C.; Berking, C.; Hassel, J.; Kähler, K. C.; Utikal, J.; Al~ghazal, P.; Gutzmer, R.; Goldinger, S. M.; Zimmer, Lisa; Paschen, Annette; Hillen, Uwe; Schadendorf, Dirk
    Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma
    In: Annals of Oncology, Jg. 25, 2014, Nr. 3, S. 747 – 753
    DOI
  • Vaubel, Julia Marianne; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa
    Retarded low-dose doxycycline for EGFR or MEK inhibitor-induced papulopustular rash
    In: Journal of the European Academy of Dermatology and Venereology, Jg. 28, 2014, Nr. 12, S. 1685 – 1689
    DOI
  • Livingstone, Elisabeth; Hollestein, Loes M; van Herk-Sukel, Myrthe P P; van de Poll-Franse, Lonneke; Joosse, Arjen; Schilling, Bastian; Nijsten, Tamar; Schadendorf, Dirk; de Vries, Esther
    Statin use and its effect on all-cause mortality of melanoma patients : a population-based Dutch cohort study
    In: Cancer Medicine, Jg. 3, 2014, Nr. 5, S. 1284 – 1293
    DOI (Open Access)
  • Griewank, Klaus; Murali, Rajmohan; Puig-Butille, Joan Anton; Schilling, Bastian; Livingstone, Elisabeth; Potrony, Miriam; Carrera, Cristina; Schimming, Tobias; Möller, Inga; Schwamborn, Marion; Sucker, Antje; Hillen, Uwe; Badenas, Celia; Malvehy, Josep; Zimmer, Lisa; Scherag, Andre; Puig, Susanne; Schadendorf, Dirk
    TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma
    In: Journal of the National Cancer Institute (JNCI), Jg. 106, 2014, Nr. 9
    DOI
  • Rompoti, Natalia; Schilling, Bastian; Livingstone, Elisabeth; Griewank, Klaus; Hillen, Uwe; Sauerwein, Wolfgang; Pöttgen, Christoph; Stuschke, Martin; Schadendorf, Dirk; Zimmer, Lisa
    Combination of BRAF inhibitors and brain radiotherapy in patients with metastatic melanoma shows minimal acute toxicity
    In: Journal of Clinical Oncology (JCO), Jg. 31, 2013, Nr. 30, S. 3844 – 3845
    DOI
  • Griewank, Klaus; Westekemper, Henrike; Schilling, Bastian; Livingstone, Elisabeth; Schimming, Tobias; Sucker, Antje; Hillen, Uwe; Steuhl, Klaus-Peter; Zimmer, Lisa; Schadendorf, Dirk; Steuhl, Klaus-Peter
    Conjunctival Melanomas Harbor BRAF and NRAS Mutations—Response
    In: Clinical Cancer Research, Jg. 19, 2013, Nr. 22, S. 6331 – 6332
    DOI
  • Griewank, Klaus; Westekemper, Henrike; Murali, Rajmohan; Mach, Monika; Schilling, Bastian; Wiesner, Thomas; Schimming, Tobias; Livingstone, Elisabeth; Sucker, Antje; Grabellus, Florian; Metz, Claudia; Süsskind, Daniela; Hillen, Uwe; Speicher, Michael R.; Woodman, Scott E.; Steuhl, Klaus-Peter; Schadendorf, Dirk
    Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas
    In: Clinical Cancer Research, Jg. 19, 2013, Nr. 12, S. 3143 – 3152
    DOI
  • Schadendorf, Dirk; Livingstone, Elisabeth; Vaubel, Julia; Zimmer, Lisa
    Hautkrebsforschung reloaded : Paradigmenwechsel in der Dermatoonkologie
    In: Unikate: Berichte aus Forschung und Lehre, 2013, Nr. 44: Medizin: 50 Jahre Universitätsklinikum Essen, S. 136 – 143
    DOI, Online Volltext (Open Access)
  • Miller, Dorothea; Zappala, Valeria; El Hindy, Nicolai; Livingstone, Elisabeth; Schadendorf, Dirk; Sure, Ulrich; Sandalcioglu, Ibrahim Erol
    Intracerebral metastases of malignant melanoma and their recurrences : a clinical analysis
    In: Clinical Neurology and Neurosurgery, Jg. 115, 2013, Nr. 9, S. 1721 – 1728
    DOI
  • Rompoti, N.; Schilling, Bastian; Livingstone, Elisabeth; Griewank, Klaus; Hillen, Uwe; Sauerwein, Wolfgang; Pöttgen, Christoph; Stuschke, Martin; Schadendorf, Dirk; Zimmer, Lisa
    Kombination von BRAF-Inhibitoren (BRAFi) und zerebraler Bestrahlung bei Patienten mit metastasiertem Melanom : Eine mögliche Behandlungsoption für neu aufgetretene oder pro-grediente Hirnmetastasen unter Therapie mit BRAF-Inhibitoren
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 11, 2013, Nr. 9, S. 952 – 952
  • Livingstone, Elisabeth; Hollestein, L. M.; Herk-Sukel, M. P. P. van; Poll-Franse, L. van de; Nijsten, T.; Schadendorf, Dirk; Vries, E. de
    β-Blocker use and all-cause mortality of melanoma patients : results from a population-based Dutch cohort study
    In: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 18, S. 3863 – 3871
    DOI
  • Schadendorf, Dirk; Vaubel, Julia Marianne; Livingstone, Elisabeth; Zimmer, Lisa
    Advances and perspectives in immunotherapy of melanoma
    In: Annals of Oncology, Jg. 23, 2012, Nr. Suppl. 10, S. x104 – x108
    DOI, Online Volltext
  • Zimmer, Lisa; Hillen, Uwe; Livingstone, Elisabeth; Lacouture, Mario E.; Busam, Klaus; Carvajal, Richard D.; Egberts, Friederike; Hauschild, Axel; Kashani-Sabet, Mohammed; Goldinger, Simone M.; Dummer, Reinhard; Long, Georgina V.; McArthur, Grant; Scherag, Andre; Sucker, Antje; Schadendorf, Dirk
    Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition
    In: Journal of Clinical Oncology (JCO), Jg. 30, 2012, Nr. 19, S. 2375 – 2383
    DOI
  • Livingstone, Elisabeth; Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Current advances and perspectives in the treatment of advanced melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 10, 2012, Nr. 5, S. 319 – 325
    DOI
  • Zimmer, Lisa; Livingstone, Elisabeth; Rüffer, J.; Jordan, K.
    Nebenwirkungsmanagement von Afatinib
    In: TumorDiagnostik & Therapie, Jg. 33, 2012, Nr. 3, S. 154 – 161
    DOI
  • Zimmer, Lisa; Livingstone, Elisabeth; Hillen, Uwe; Dom̈kes, Stephanie; Becker, Arne; Schadendorf, Dirk
    Panniculitis With Arthralgia in Patients With Melanoma Treated With Selective BRAF Inhibitors and Its Management
    In: Archives of Dermatology, Jg. 148, 2012, Nr. 3, S. 357 – 361
    DOI
  • Zimmer, Lisa; Vaubel, Julia Marianne; Livingstone, Elisabeth; Schadendorf, Dirk
    Side effects of systemic oncological therapies in dermatology
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 10, 2012, Nr. 7, S. 475 – 486
    DOI
  • Livingstone, Elisabeth; Windemuth-Kieselbach, Christine; Eigentler, Thomas K.; Rompel, Rainer; Trefzer, Uwe; Nashan, Dorothee; Rotterdam, Sebastian; Ugurel, Selma; Schadendorf, Dirk
    A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up
    In: European Journal of Cancer (EJC), Jg. 47, 2011, Nr. 13, S. 1977 – 1989
    DOI
  • Livingstone, Elisabeth; Trarbach, Tanja; Zimmer, Lisa; Schuler, Martin; Schadendorf, Dirk
    EGFR-Inhibitoren und Multityrosinkinaseinhibitoren : Interdisziplinäre Behandlung der kutanen Nebenwirkungen
    In: Deutsche Medizinische Wochenschrift - DMW, Jg. 136, 2011, Nr. 1-2, S. 39 – 44
    DOI
  • Egberts, F.; Gutzmer, R.; Ugurel, Selma; Becker, J.C.; Trefzer, U.; Degen, A.; Schenck, F.; Frey, L.; Wilhelm, T.; Hassel, J.C.; Schadendorf, Dirk; Livingstone, Elisabeth; Mauch, C.; Garbe, C.; Berking, C.; Rass, K.; Mohr, P.; Kaehler, K.C.; Weichenthal, M.; Hauschild, A.
    Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma : A multicenter phase II DeCOG trial
    In: Annals of Oncology, Jg. 22, 2011, Nr. 7, S. 1667 – 1674
    DOI
  • Livingstone, Elisabeth; Caliebe, Almuth; Egberts, Friederike; Proksch, Ehrhardt; Buiting, Karin; Schubert, Carola; Claviez, Alexander; Siebert, Reiner; Hauschild, Axel
    Malignant melanoma and Wiedemann-Beckwith syndrome in childhood
    In: Klinische Pädiatrie, Jg. 222, 2010, Nr. 6, S. 388 – 390
    DOI
  • Livingstone, Elisabeth; Zimmer, Lisa; Piel, S.; Schadendorf, Dirk
    PLX4032 : does it keep its promise for metastatic melanoma treatment?
    In: Expert Opinion on Investigational Drugs, Jg. 19, 2010, Nr. 11, S. 1439 – 1449
    DOI
  • Kaehler, K. C.; Piel, S.; Livingstone, Elisabeth; Schilling, Bastian; Hauschild, A.; Schadendorf, Dirk
    Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma : Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
    In: Seminars in Oncology, Jg. 37, 2010, Nr. 5, S. 485 – 498
    DOI

    • Vorworte / Nachworte

  • Berking, Carola; Hassel, Jessica C.; Livingstone, Elisabeth
    Fertilitätserhalt beim Melanom  : eine große Entlastung der Betroffenen
    In: Die Dermatologie. Berlin: Springer Medizin, Jg. 74, 2023, Nr. 7, S. 479 – 480
    DOI (Open Access)

    • Abstracts

  • Livingstone, Elisabeth; Forschner, A.; Hassel, J.C.; von Wasielewski, I.; Meier, F.; Mohr, P.; Kähler, K.C.; Schilling, B.; Erdmann, M.; Berking, C.; Huning, S.; Stege, H.; Gutzmer, R.; Kowall, Bernd; Stang, Andreas; Galetzka, W.; Hauschild, A.; Zimmer, Lisa; Schadendorf, Dirk; Lodde, Georg
    Adjuvant treatment of patients with stage III melanoma : 4-year follow-up time of multicenter real-world study
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S740
    DOI
  • Borgers, Jessica S.W.; Johnson, Douglas Buckner; Livingstone, Elisabeth; Buchbinder, Elizabeth Iannotti; Robinson, William A.; Hamid, Omid; Ferreira, Michelle; Dimitriou, Florentia; Long, Georgina V.; Ascierto, Paolo Antonio; Daletzakis, Antonios; Najjar, Yana G.; Hospers, Geke; Choi, Jacob Seung; Amant, Frederic; Tsai, Katy K.; Eroglu, Zeynep; Haanen, John; Glitza, Isabella Claudia
    Advanced stage melanoma during pregnancy : Real-world management
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, 9540
    DOI
  • Leven, A. S.; Peters, T.; Rajcsanyi, L.S.; Tasdogan, Alpaslan; Placke, Jan-Malte; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Rösch, Alexander; Hinney, Anke; Ugurel, Selma
    Analysis of gender-specific Differences in Response to First-line Treatment with Immunotherapy or targeted Therapy in Melanoma Patients with metastatic Stage IV Melanoma : An ADO/DeCOG Study of 2032 Patients from the prospective, multicenter Skin Cancer Registry ADOREG
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 22, 2024, Nr. Suppl. 4, S. 16 – 17
    DOI
  • Lodde, Georg; Kowall, Bernd; Stang, Andreas; Galetzka, W.; Zaremba-Montenari, Anne; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Correlation of Laboratory Parameters at the Start of adjuvant Treatment of Stage III Melanoma Patients with clinical Outcome : A multicenter Real World Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 22, 2024, Nr. Suppl. 4, S. 8 – 9
    DOI
  • Tarantino, G.; Zaremba-Montenari, Anne; Vallius, T.; Rambow, F.; Zimmer, Lisa; Sucker, A.; Livingstone, Elisabeth; Hadaschik, Eva; Pelletier, R.; Shi, Y.; Lopez Leon, M.; Makhzami, S.; Lian, C.; Murphy, G.; Sorger, P.; Liu, D.; Schadendorf, Dirk
    Deciphering unresectable in-transit metastasis in melanoma : Multi-modal and longitudinal insights
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S736
    DOI
  • Elsayad, K.; Kandler, C.; Siats, J.J.; Pepper, N.; Danzer, M.F.; Dobos, G.; Livingstone, Elisabeth; Melchers, S.; Kleemann, J.; Hyun, J.; Pföhler, C.; von den Driesch, P.; Nicolay, J.P.; Stadler, R.; Eich, H.T.
    Durable disease control with low-dose total skin electron beam therapy combined with maintenance treatment for patients with erythrodermic mycosis fungoides and Sézary syndrome
    EORTC-CLTG 2024, 9-11 October 2024, Lausanne, Switzerland,
    In: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 211, 2024, Nr. Supplement 2, 114477
    DOI
  • Schadendorf, Dirk; Gogas, H.; Kandolf Sekulovic, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.; Gesierich, A.; Herbst, R.; Kähler, K.C.; Ziogas, D.C.; Mijušković, Ž.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel-Becker, Selma; Gutzmer, R.; Grob, J.J.; Zimmer, Lisa; Livingstone, Elisabeth
    Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma : Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S1235 – S1236
    DOI
  • Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Lodde, Georg; Tasdogan, Alpaslan; Becker, Jürgen; Griewank, Klaus; Hadaschik, Boris; Schadendorf, Dirk; Ugurel, Selma
    PD-L1 Expression in Lymph Node Metastases as a Predictor of adjuvant Immunotherapy Success in Stage III Melanoma Patients: An Analysis of the prospective ADOREG Study TRIM-ADJUVANT
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 22, 2024, Nr. Suppl. 4, S. 15 – 16
    DOI
  • Kuper, A.; Krämer, Nicole; Livingstone, Elisabeth; Schadendorf, Dirk; Lodde, Georg
    Psychological Characteristics and their Impact on Trust in AI in dermatological Decision Making
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 22, 2024, Nr. Suppl. 4, S. 34 – 35
    DOI
  • Schielke, L.; Hadaschik, Eva; Lodde, Georg; Albrecht, Jessica Lea; Sucker, A.; Tasdogan, Alpaslan; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Ugurel, Selma; Placke, Jan-Malte
    The PD-L1 Expression predicts the Outcome of anti-PD-1/PD-L1-based Immune Checkpoint Therapy in Patients with metastatic Merkel Cell Carcinoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 22, 2024, Nr. Suppl. 4, S. 17 – 18
    DOI
  • Livingstone, Elisabeth
    Use of pegylated Interferon-α2a in Patients with cutaneous T-Cell Lymphoma : A multicenter retrospective Data Analysis with 70 Patients from the ADO Lymphoma Network
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 22, 2024, Nr. Suppl. 4, S. 14
    DOI
  • Hansen, I.; Geidel, G.; Abeck, F.; Kött, J.; Cankaya, R.; Dobos, Gustav; Mitteldorf, C.; Nicolay, J.P.; Albrecht, J.D.; Menzer, C.; Livingstone, Elisabeth; Mengoni, M.; Braun, A.D.; Wobser, M.; Klemke, C.-D.; Tratzmiller, S.; Assaf, C.; Terheyden, P.; Klespe, K.-C.; Schneider, S.W.; Booken, N.
    Use of pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicentre retrospective data analysis with 70 patients
    In: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 211, 2024, Nr. Suppl. 2, 114416
    DOI
  • Becker, Jürgen C.; Schilling, B.; Leiter-Stoppke, U.; Zimmer, Lisa; Hassel, J.C.; von Wasielewski, I.; Ziemer, M.; Fluck, M.; Meier, F.; Spillner, A.; Gesierich, A.; Eigentler, T.; Livingstone, Elisabeth; Albers, M.; Angela, Y.; Gutzmer, R.
    A single arm phase II, multicenter trial to evaluate the clinical activity and safety of avelumab plus cetuximab in unresectable stage III or IV cutaneous squamous cell carcinoma : First results from the AliCe study
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S654 – S655
    DOI
  • Zillikens, H.; Scheib, C.; Peller, V.; Müller, C.; Bauer, Sebastian; Pretzell, I.; Griewank, Klaus; Sucker, A.; Hadaschik, Eva; Guntrum, F.; Baum, S.H.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Außergewöhnlicher Therapiebenefit von Imatinib bei cKIT-mutiertem Schleimhautmelanom mit nachfolgendem KIT-Mutationsverlust
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21 – 22
    DOI (Open Access)
  • Placke, Jan-Malte; Kimmig, M.; Griewank, Klaus; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Welzel, J.; Engel, Daniel Robert; Kreft, S.; Sucker, A.; Krefting, F.; Lodde, Georg C.; Stoffels, Ingo; Klode, Joachim; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Becker, Jürgen C.; Weichenthal, M.; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma
    Die PD-L1-Expression im Tumor prognostiziert je nach Art des untersuchten Gewebes das Outcome einer Anti-PD-1-basierten Immuntherapie bei metastasiertem Melanom
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 27 – 28
    DOI (Open Access)
  • Jansen, Philipp; Galetzka, W.; Lodde, Georg C.; Zaremba, Anne; Standl, F.; Landsberg, J.; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pföhler, C.; Ulrich, J.; Placke, Jan-Malte; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Weichenthal, M.; Möller, I.; Sucker, A.; Paschen, Annette; Hadaschik, Eva; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Ugurel, Selma; Stang, Andreas; Griewank, Klaus
    Molekulare und klinische Charakterisierung von BRAF/NRAS/NF1-wt Melanomen
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21
    DOI (Open Access)
  • Galetzka, W.; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Kowall, Bernd; Stang, Andreas
    Treatment decision for melanoma patients : Identification of similar patients at point of care
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO-Jahrestagung) 06.–09. September 2023 Hamburg, S. 5 – 6
    DOI (Open Access)
  • Elsayad, Khaled; Weishaupt, Carsten; Moustakis, Christos; Müller, Elisa Christina; Rolf, Daniel; Stranzenbach, Rene; Livingstone, Elisabeth; Booken, Nina; Stadler, Rudolf; Eich, Hans Theodor
    Ultra-hypofraktionierte Ganzhautelektronenbestrahlung mit 2×4 Gy beim kutanen T-Zell-Lymphom
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S138 – S139
    DOI (Open Access)
  • Lodde, Georg C.; Zhao, F.; Galetzka, W.; Placke, Jan-Malte; Griewank, Klaus; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Weichenthal, M.; Sucker, A.; Paschen, Annette; Horn, S.; Jansen, Philipp; Becker, Jürgen C.; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma
    Untersuchung des klinischen Verlaufs von Melanompatienten mit einer Super-Response (CR/PR innerhalb von 3 Monaten) unter PD-1-basierter Immuncheckpoint-Inhibition : eine Subgruppen-Analyse der prospektiven multizentrischen Studie ADOREG
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 8 – 9
    DOI (Open Access)
  • Becker, Jürgen C.; Ugurel, Selma; Leiter-Stoppke, U.; Meier, F.; Gutzmer, R.; Haferkamp, S.; Zimmer, Lisa; Livingstone, Elisabeth; Eigentler, T.; Hauschild, A.; Kiecker, F.; Hassel, J.C.; Mohr, P.; Fluck, M.; Thomas, I.; Garzarolli, M.; Grimmelmann, I.; Drexler, K.; Eckhardt, S.; Schadendorf, Dirk
    Adjuvant immunotherapy with nivolumab (NIVO) versus observation in completely resected Merkel cell carcinoma (MCC) : Disease-free survival (DFS) results from ADMEC-O, a randomized, open-label phase II trial
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 33, 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S903
    DOI (Open Access)
  • Schadendorf, Dirk; Hassel, J.C.; Fluck, M.; Eigentler, T.; Loquai, C.; Haferkamp, S.; Gutzmer, R.; Meier, F.; Mohr, P.; Hauschild, A.; Menzer, C.; Kiecker, F.; Dippel, E.; Simon, J-C.; Conrad, B.; Garbe, C.; Körner, S.; Becker, Jürgen C.; Zimmer, Lisa; Livingstone, Elisabeth
    Adjuvant nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma with no evidence of disease (NED) : Overall survival (OS) results of IMMUNED, a randomized, double-blind multi-center phase II DeCOG trial
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 33, 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S900
    DOI (Open Access)
  • Franklin, Cindy; Mohr, P.; Meier, F.; Lodde, Georg; Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Horn, S.; Schadendorf, Dirk; Ugurel, Selma; et al.
    Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients : a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 13 – 14
    DOI
  • Gutzmer, R.; Weichenthal, M.; Eigentler, T.; Grimmelmann, I.; Sickmann, T.; Zimmer, Lisa; Livingstone, Elisabeth; Ugurel, Selma; Utikal, J. S.; Müller, V.; Göppner, D.; Herbst, R.; Kreuter, A.; Pföhler, C.; Hollburg, W.; Loquai, C.; Kähler, K.; Mohr, P.; Schadendorf, Dirk
    Early safety signals from nivolumab in the adjuvant treatment of real-world melanoma patients derived from the German prospective non-interventional study NICO
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 18 – 19
    DOI
  • Schadendorf, Dirk; Gogas, Helen; Kandolf Sekulovic, Lidija; Meier, Friedegund Elke; Eigentler, Thomas; Simon, Jan-Christoph; Terheyden, Patrick Andres Maximilian; Gesierich, Anja Heike; Herbst, Rudolf Alexander; Kähler, Katharina C.; Ziogas, Dimitrios C.; Mijuskovic, Zeljko; Garzarolli, Marlene; Garbe, Claus; Rösch, Alexander; Ugurel, Selma; Gutzmer, Ralf; Grob, Jean-Jacques; Zimmer, Lisa; Livingstone, Elisabeth
    Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAFV600-positive melanoma : Interim analysis of the ImmunoCobiVem study
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. 16_Suppl., S. 9548
    DOI
  • Albrecht, L. J.; Höwner, A.; Griewank, Klaus; Lueong, S. S.; von Neuhoff, N.; Horn, Peter A.; Sucker, A.; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, S.; Siveke, Jens T.; Schadendorf, Dirk; Váraljai, R.; Rösch, Alexander
    Im Plasma zirkulierende zellfreie mRNA ermöglicht die minimal-invasive und Genotyp-unabhängige Therapieüberwachung bei Patienten mit Melanom
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 12 – 13
    DOI
  • Jehn, B. L.; Waelscher, J.; Wessendorf, Thomas; Livingstone, Elisabeth; Zimmer, Lisa; Metzenmacher, M.; Eberhardt, Wilfried; Theegarten, Dirk; Taube, Christian; Bonella, Francesco
    Immune Checkpoint Inhibitor (ICI)-associated Pulmonary Manifestations (ICI-LM): Characterization of HRCT and BAL Findings
    62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,
    In: Pneumologie. Stuttgart: Thieme, Jg. 76, 2022, Nr. Supplement 1, S. S52
    DOI
  • Zaremba, Anne; Meier, F.; Schlein, C.; Jansen, Philipp; Lodde, Georg; Song, M.; Kretz, J.; Möller, I.; Stadtler, N.; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Sucker, A.; Schadendorf, Dirk; Griewank, Klaus
    Klinische und pathologische Merkmale des familiären Melanoms bei Keimbahn-TERT-Promotorvarianten
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 6
    DOI
  • Livingstone, Elisabeth; Forschner, Andrea; Hassel, Jessica Cecile; Wulfken, Lena M.; Meier, Friedegund Elke; Mohr, Peter; Kähler, Katharina C.; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Kowall, Bernd; Galetzka, Wolfgang; Hauschild, Axel; Zimmer, Lisa; Schadendorf, Dirk; Lodde, Georg
    Multicenter real-world data of adjuvant treatment and disease outcome of patients with melanoma with high-risk of recurrence
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. 16_Suppl., S. 9570
    DOI (Open Access)
  • Placke, Jan-Malte; Mohr, P.; Bluhm, L.; Engel, Daniel Robert; Franklin, Cindy; Zaremba, Anne; Krefting, F.; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen C.; Tasdogan, Alpaslan; Rösch, Alexander; Schadendorf, Dirk; Ugurel, Selma; et al.
    Predictors of long-term survival of stage IV melanoma patients : a multicenter DeCOG study on 539 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 16 – 17
    DOI
  • Schirren, AEC; Albrecht, JD; Dippel, E; Fahlbusch, S; Gosmann, J; Klemke, CD; Chang, M Laturnus; Livingstone, Elisabeth; Mitteldorf, C; Schummer, P; Stadler, R; Stranzenbach, R; Wobser, M; Ziemer, M; Nicolay, JP
    Quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas
    In: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 173, 2022, Nr. Suppl. 1, S. 20
    DOI
  • Lodde, Georg; Forschner, A.; Hassel, J. C.; Wulfken, L. M.; Meier, F.; Mohr, P.; Kähler, K.; Schilling, Bastian; Loquai, C.; Berking, C.; Hüning, S.; Eckardt, J.; Gutzmer, R.; Reinhardt, L.; Glutsch, V.; Nikfarjam, U.; Erdmann, M.; Kowall, Bernd; Galetzka, W.; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Therapiemanagement des ersten Rezidivs nach adjuvanter Therapie im Stadium III : multizentrische real-world Daten
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 3
    DOI
  • Jehn, Lutz-Bernhard; Wälscher, Julia; Wessendorf, Thomas; Livingstone, Elisabeth; Zimmer, Lisa; Metzenmacher, Martin; Eberhardt, Wilfried; Theegarten, Dirk; Bonella, Francesco
    Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)
    In: European Respiratory Journal (ERJ). Sheffield: European Respiratory Society, 2021, OA4240
    DOI (Open Access)
  • Bhave, Prachi; Hong, Angela M.; Johnson, Rebecca; Menzies, Alexander M.; Long, Georgina V.; Mangana, Joanna; Johnson, Douglas Buckner; Eroglu, Zeynep; Dulgar, Ozgecan; Yeoh, Hui-Ling; Haydon, Andrew Mark; Lodde, Georg; Livingstone, Elisabeth; Khattak, Muhammad Adnan; Kähler, Katharina C.; Hauschild, Axel; Wang, Wei; Carlino, Matteo S.
    Efficacy of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy.
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 15_Suppl., S. 9578 – 9578
    DOI (Open Access)
  • Elsayad, K.; Rolf, D.; Sunderkoetter, C.; Weishaupt, C.; Müller, E.; Nawar, T.; Stranzenbach, R.; Livingstone, Elisabeth; Stadler, R.; Steinbrinck, K.; Moritz, R.; Eich, H. T.
    Efficacy of low-dose Total Skin Electron Irradiation followed by oral Maintenance Retinoids in Patients with Mycosis Fungoides and Sezary Syndrome
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 172
  • Fischedick, G.; Pöttgen, Christoph; Lübcke, Wolfgang; Gauler, Thomas; Guberina, M.; Guberina, N.; Pierscianek, D.; Livingstone, Elisabeth; Hense, Jörg; Eberhardt, Wilfried; Stuschke, Martin
    Image-guided ablative Radiotherapy for Patients with multiple cerebral Metastases using Precision helical Irradiation
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 183
  • Zaremba, Anne; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa
    Immune checkpoint-Inhibition in Patients with NRAS-mutated Melanoma compared to Patients with NRAS Wild-type Melanoma : Results of a Study on 702 Patients from the prospective, multicenter Registry ADOREG
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 59 – 60
  • Ugurel, Selma; Griewank, Klaus; Horn, S.; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pfoehler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Sucker, A.; Placke, Jan-Malte; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Becker, Jürgen; Weichenthal, M.; Schadendorf, Dirk
    PD-L1-Expression and Mutation Profile in pre-therapeutic Tumor Tissue as Predictors of the Therapeutic Success of PD-1-based Immune Checkpoint Inhibition Therapy in Patients with metastatic Melanoma : Evaluation of the prospective multicentric ADO-Study TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 19
  • Albrecht, L. J.; Grünwald, Viktor; Becker, Jürgen; Gutzmer, R.; Asan, L.; Uslar, E.; Olischewsky, A.; Mueseler, A. C.; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    PTHrP-induced hypercalcemia Psychosyndrome under Immune Checkpoint Blockade in Patients with penile Squamous Cell Carcinoma
    31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, Hamburg, Germany and Virtual,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 23
    DOI (Open Access)
  • Lodde, Georg; Ugurel, Selma; Placke, Jan-Malte; Griewank, Klaus; Sucker, A.; Jansen, Philipp; Becker, Jürgen; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Schadendorf, Dirk
    Predictors of Super-response (CR/PR within 3 Months) under PD-1-based Immune Checkpoint Inhibition in metastatic Melanoma : A Subgroup Analysis of the prospective multicenter Study ADOREG TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 6 – 7
  • Thielmann, Carl Maximilian; Matull, J.; Zaremba, Anne; Chorti, E.; Lodde, Georg; Jansen, Philipp; Kretz, J.; Möller, I.; Sucker, A.; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus
    TERT Promoter Mutations associated with longer progression-free and Overall Survival under BRAF/MEK Therapy
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 31
  • Schadendorf, Dirk; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa
    Termination of targeted Therapy with BRAF-/MEK Inhibitors after an initial complete Response in Patients with metastatic Melanoma and its clinical Implications : A retrospective, multicenter ADOReg Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 15 – 16
  • Zimmer, Lisa; Krackhardt, Angela; Schultz, Erwin S.; Goeppner, Daniela; Assaf, Chalid; Trebing, Dietrich; Livingstone, Elisabeth; Schadendorf, Dirk
    Triplet therapy with pembrolizumab (PEM), encorafenib (ENC) and binimetinib (BIN) in advanced, BRAF V600 mutant melanoma : Final results from the dose-finding phase I part of the IMMU-Target trial
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 15_Suppl, S. 9532 – 9532
    DOI (Open Access)
  • Placke, Jan-Malte; Soun, C.; Bottek, J.; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, A.; Griewank, Klaus; Horn, S.; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Engel, Daniel Robert; Ugurel, Selma
    Tumor PD-L1-Positivity in medical and digital Quantification predicts a favorable Patient Outcome for a PD-1-based Immune Checkpoint-Blockade in metastatic Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 58 – 59
  • Zaremba, Anne; Martaki, Anna; Salzmann, Martin; Baroudjian, Barouyr; Sachse, Michael M.; Gesierich, A.; Reinhardt, Lydia; Meier, F.; Hassel, Jessica C.; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth; Broeckelmann, Paul; Kramer, R.; Heinzerling, L.; Zimmer, Lisa
    Agranulozytose unter Immuncheckpoint‐Blockade : Eine retrospektive, multizentrische Auswertung
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV28
    DOI (Open Access)
  • Placke, Jan-Malte; Rawitzer, J.; Reis, Henning; Livingstone, Elisabeth; Ugurel, Selma; Hadaschik, Eva; Schmid, Kurt Werner; Rösch, Alexander; Zimmer, Lisa
    Apoptotische Gastritis nach Immuncheckpointblockade : Ein typisches histopathologisches Muster
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P12
    DOI (Open Access)
  • Placke, Jan-Malte; Ugurel, Selma; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Schadendorf, Dirk; Funke-Lorenz, Carolin
    Die Extracorporale Photopherese verbessert therapierefraktäre autoimmune Nebenwirkungen nach Immuncheckpointblockade
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV06
    DOI (Open Access)
  • Franklin, Cindy; Wetter, Axel; Baba, Hideo Andreas; Cosgarea, Ioana; Mauch, Cornelia; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Ugurel, Selma
    Die diagnostische Bedeutung der CT-gesteuerten Punktion bei Hauttumorpatienten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV49
    DOI (Open Access)
  • Placke, Jan-Malte; Soun, Camille; Bottek, Jenny; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pfoehler, Claudia; Ulrich, Jens; Kreuter, Alexander; Pfeiffer, Constance M.; Mohr, Peter; Gutzmer, Ralf; Meier, F.; Dippel, Edgar; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, Antje; Griewank, Klaus; Horn, Susanne; Hadaschik, Eva; Rösch, Alexander; Engel, Daniel Robert; Schadendorf, Dirk; Ugurel, Selma
    Die digitale Analyse der Tumor PD‐L1 Expression ist ein guter Prädiktor des Therapieerfolgs einer anti‐PD1‐basierten Immuntherapie : Eine Subgruppenanalyse der multizentrischen translationalen Studie ADOREG/TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV36
    DOI (Open Access)
  • Lodde, Georg; Ruebben, Albert; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Placke, Jan-Malte; Griewank, Klaus; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma
    Eindrucksvolles und schnelles Therapieansprechen eines metastasierten Adnexkarzinoms unter Cemiplimab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV08
    DOI (Open Access)
  • Olischewsky, Alexandra; Schneider, M.; Koch, Fiona; Lodde, Georg; Alt, Clemens; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Neoadjuvante Immun‐ und zielgerichtete Therapie bei Melanompatienten im Stadium III B
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV44
    DOI (Open Access)
  • Lodde, Georg; Forschner, Andrea; Wulfken, Lena M.; Meier, F.; Mohr, Peter; Kaehler, Katharina C.; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Gebhardt, C.; Huening, Svea; Schatton, Kerstin; Eckardt, Josephine; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Stang, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Therapieentscheidung bei Indikation zur adjuvanten Therapie des Melanoms : Multizentrische Real World Data
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV43
    DOI (Open Access)
  • Albrecht, M.; Hadaschik, Eva; Zimmer, L.; Livingstone, Elisabeth; Hamacher, R.; Bauer, Sebastian; Schadendorf, Dirk; Ugurel, Selma
    Angiosarkom im Bereich des Capillitium mit der Symptomatik eines Quincke‐Ödems
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. Suppl. 6, S. 34
    DOI (Open Access)
  • Kanaki, T.; Knispel, Sarah; Chorti, E.; Albrecht, M.; Martaki, A.; Zaremba, Anne; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Auswirkungen der überarbeiteten AJCC‐Klassifikation (8. Edition) auf das Essener Melanomkollektiv
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 61 – 62
    DOI (Open Access)
  • Placke, Jan-Malte; Knispel, Sarah; Chorti, E.; Albrecht, M.; Kanaki, T.; Jockenhöfer, Finja; Martaki, A.; Zaremba, Anne; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Autoimmunbedingte Gastritis nach Immuncheckpoint‐Blockade : eine Fallserie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 26 – 27
    DOI (Open Access)
  • Kubat, L.; Schrama, D.; Melior, Anita; Herbst, R.; Terheyden, P.; Utikal, J.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Pfeiffer, C.; Mohr, P.; Gutzmer, R.; Schilling, Bastian; Sucker, A.; Meier, F.; Dippel, E.; Kaatz, M.; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Becker, Jürgen
    CCR5 Δ32 Polymorphismus als prädiktiver Marker für die Therapie mit Immuncheckpoint‐Inhibitoren beim Melanom
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 49 – 50
    DOI (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Bauer, Sebastian; Podleska, Lars; Schulz, A.; Schimming, Tobias; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Clear Cell Sarcoma - a rare Differential Diagnosis of malignant Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. Suppl. 6, S. 3
  • Ugurel, Selma; Horn, S.; Griewank, Klaus; Sucker, A.; Herbst, R.; Terheyden, P.; Utikal, J.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Pfeiffer, C.; Mohr, P.; Gutzmer, R.; Weyandt, G.; Meier, F.; Dippel, E.; Kaatz, M.; Weichenthal, M.; Schilling, Bastian; Becker, Jürgen; Zimmer, Lisa; Livingstone, Elisabeth; Rebmann, Vera; Schadendorf, Dirk
    Die Anzahl mutierter Melanom‐assoziierter Gene und die Expression von PD‐L1 sind unabhängige Prädiktoren der anti‐PD1 Immuntherapie ‐ eine prospektive Registerstudie der ADO (ADOREG/TRIM)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 7 – 8
    DOI (Open Access)
  • Knispel, Sarah; Zimmer, Lisa; Gutzmer, R.; Heinzerling, L.; Weishaupt, C.; Pföhler, C.; Gesierich, A.; Herbst, R.; Kähler, K.; Weide, B.; Schlaak, M.; Loquai, C.; Utikal, J.; Terheyden, P.; Kaatz, M.; Berking, C.; Kreuter, A.; Ulrich, J.; Mohr, P.; Dippel, E.; Weichenthal, M.; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Einfluss einer vorangegangenen Radiatio auf den Erfolg einer immunonkologischen Therapie beim metastasierten Melanom – eine retrospektive multizentrische Studie der ADO
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 28 – 29
    DOI (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Bauer, Sebastian; Podleska, Lars; Schulz, Andrea; Schimming, T.; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Klarzellsarkom – eine seltene Differentialdiagnose des malignen Melanoms
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 3
    DOI (Open Access)
  • Chorti, E.; Keyvani, Kathy; Umutlu, Lale; Kanaki, T.; Zaremba, Anne; Jockenhöfer, Finja; Knispel, Sarah; Placke, Jan-Malte; Albrecht, M.; Martaki, A.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Glas, M.; Zimmer, Lisa
    Meningeosis melanomatosa : Schlechte Prognose trotz neuer Systemtherapeutika
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 11 – 12
    DOI (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Schadendorf, Dirk; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Partielle Remission eines fortgeschrittenen Melanoms durch eine Kombinationstherapie mit Nivolumab und Trametinib nach Therapieversagen unter Ipilimumab + Nivolumab
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 38
    DOI (Open Access)
  • Bischof, L.; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Hadaschik, Eva; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Therapieversagen der Immuncheckpoint‐Blockade mit PD1‐Antikörpern bei Patienten mit metastasierten Hauttumorerkrankungen und gleichzeitiger Immunsuppression durch eine Chronisch Lymphatische Leukämie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 28
    DOI (Open Access)
  • Chorti, E.; Tiedje, Vera; Zaremba, Anne; Jockenhöfer, Finja; Hoge, J.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Führer, Dagmar; Livingstone, Elisabeth; Zimmer, Lisa
    Diagnostik und Therapie der immunvermittelten Thyreoiditis unter Therapie mit Ipilimumab und Nivolumab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 15, 2017, Nr. Suppl. 3, S. 26 – 27
    DOI
  • Kähler, Katharina C.; Kornek, Thomas; Blome, Christine; Wagner, Tobias; Utikal, Jochen; Gebhardt, Christoffer; Gutzmer, Ralf; Schenck, Florian; Livingstone, Elisabeth; Schadendorf, Dirk; Loquai, Carmen; Rudolph, Berenice M.; Mohr, Peter; Forschner, Andrea; Garbe, Claus; Terheyden, Patrick; Angün, Ozan; Stade, Barbara; Augustin, Matthias; Hauschild, Axel
    The GERMELATOX DeCOG-trial : German melanoma patients and their attitude toward toxicity during adjuvant interferon treatment
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 32, 2014, Nr. 15, suppl., S. TPS9113
    DOI

    • Beiträge in Sammelwerken und Tagungsbänden

  • Beckmann, Catharina Lena; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Böckmann, Britta
    Guideline-Based Context-Sensitive Decision Modeling for Melanoma Patients
    In: German Medical Data Sciences 2022 – Future Medicine: More Precise, More Integrative, More Sustainable! / Joint Conference of the 67th Annual Meeting of the German Association of Medical Informatics, Biometry, and Epidemiology e.V. (gmds) and the 14th Annual Meeting of the TMF – Technology, Methods, and Infrastructure for Networked Medical Research e.V.; 21–25 August 2022; Kiel, Germany / Röhrig, Rainer; Grabe, Niels; Hoffmann, Verena S.; Hübner, Ursula; König, Jochem; Sax, Ulrich; Schreiweis, Björn; Sedlmayr, Martin (Hrsg.). Amsterdam: IOS Press, 2022, S. 50 – 57
    DOI (Open Access)

    • Working Paper

  • Küper, Alisa; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Krämer, Nicole
    Supporting Dermatologists with Explainable Ai : Exploring the Effects of Consistency and Explanation Approaches
    2024
    DOI

    • Poster / Posterbeiträge

  • Albrecht, L. J.; Dimitriou, F.; Grover, P.; Hassel, J. C.; Erdmann, M.; Forschner, A.; Johnson, D.; Livingstone, Elisabeth; Rösch, Alexander; Ugurel, Selma; Schulz, C.; Berking, C.; Menzies, A. M.; Long, G. V.; Dummer, R.; Schadendorf, Dirk; Zimmer, Lisa
    Anti-PD1 plus BRAF/MEK inhibitors (triplet therapy) after failure of standard therapy in patients (pts) with advanced melanoma
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 44
    DOI (Open Access)
  • Scheib, C.; Zillikens, H.; Peller, V.; Müller, C.; Rudolph, V.; Leven, A. S.; Griewank, Klaus; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Ausgedehntes Rezidiv eines atypischen Fibroxanthoms
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO-Jahrestagung) 06.–09. September 2023 Hamburg, S. 99
    DOI (Open Access)
  • Kühn, L. M.; Nashan, D.; Graf, K.; Livingstone, Elisabeth; Gutzmer, R.; Meier, F.; Dücker, P.; Hüning, S.
    Einfluss der Hygieneregeln im Rahmen der Covid-19-Pandemie auf das psychosoziale Empfinden stationärer Hauttumor-Patienten
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 52 – 53
    DOI (Open Access)
  • Borys, K.; Bloch, L.; Galetzka, W.; Livingstone, Elisabeth; Lodde, Georg C.; Schadendorf, Dirk; Friedrich, C. M.; Nensa, Felix
    Identifizierung von nachteiligen Datensamples zur verbesserten KI-gestützten Klassifizierung von Hautläsionen unter Verwendung von Radiomics
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 95 – 96
    DOI (Open Access)
  • Rudolph, V.; Leven, A. S.; Peller, V.; Müller, C.; Scheib, C.; Zillikens, H.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Langfristiger Therapieerfolg von sequentieller Immun- und zielgerichteter Therapie beim metastasierten malignen Melanom
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 47 – 48
    DOI (Open Access)
  • Lodde, Georg C.; Dollani, J.; Galetzka, W.; Stang, Andreas; Ugurel, Selma; Rösch, Alexander; Zaremba, Anne; Sucker, A.; Zimmer, Lisa; Schadendorf, Dirk; Griewank, Klaus; Livingstone, Elisabeth
    Melanom mit unbekanntem Primarius (MUP) - eine monozentrische Auswertung
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 76 – 77
    DOI (Open Access)
  • Tarantino, G.; Zaremba, Anne; Vallius, T.; Rambow, F.; Zimmer, Lisa; Sucker, A.; Livingstone, Elisabeth; Pelletier, R.; Makhzami, S.; Murphy, G.; Lian, C.; Sorger, P.; Liu, D.; Schadendorf, Dirk
    Multi-modal and longitudinal characterization of the tumor and immune microenvironment from primary melanoma to in-transit and distant metastasis
    ESMO Congress 2023 ; 20 - 24 October 2023 Madrid, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S694
    DOI (Open Access)
  • Hartmann, E. M.; Nensa, Felix; Lodde, Georg C.; Livingstone, Elisabeth; Schadendorf, Dirk; Sachweh, S.
    Pain points in software interaction in the treatment of melanoma patients
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 125 – 126
    DOI (Open Access)
  • Idrissi-Yaghir, A.; Schäfer, H.; Lodde, Georg C.; Livingstone, Elisabeth; Schadendorf, Dirk; Friedrich, C.M.
    Preliminary Examination of Cited Literature in International Melanoma Guidelines
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 126
    DOI (Open Access)
  • Müller, C.; Scheib, C.; Peller, V.; Zillikens, H.; Rudolph, V.; Leven, A. S.; Bauer, Sebastian; Pretzell, I.; Griewank, Klaus; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Therapieansprechen auf Sunitinib bei Imatinib-resistentem Rezidiv eines Dermatofibrosarkoma protuberans am Capillitium
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 99 – 100
    DOI (Open Access)
  • Peller, V.; Müller, C.; Zillikens, H.; Scheib, C.; Viktoria, R.; Rösch, Alexander; Ugurel, Selma; Becker, Jürgen C.; Gutzmer, R.; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Therapieoption beim lokal fortgeschrittenen kutanen Plattenepithelkarzinom nach Cemiplimab-Resistenz
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 72
    DOI (Open Access)
  • Beckmann, C. L.; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Böckmann, B.
    Context-Sensitive Modeling of a Standard Operating Procedure for Melanoma Patient Treatment
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 67
    DOI
  • Borys, K.; Livingstone, Elisabeth; Lodde, Georg; Seifert, Christin; Krämer, Nicole; Umutlu, Lale; Schadendorf, Dirk; Friedrich, C. M.; Nensa, Felix
    Explainable Radiomics by the example of malignant melanoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 65 – 66
    DOI
  • Zaremba, Anne; Jansen, Philipp; Murali, R.; Mayakonda, A.; Riedel, A.; Krahl, D.; Burkhardt, H.; John, S.; Géraud, C.; Philip, M.; Kretz, J.; Möller, I.; Stadtler, N.; Sucker, A.; Paschen, Annette; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Horn, S.; Plass, C.; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, P.; Griewank, Klaus
    Genetic and methylation analysis of CTNNB1 mutations in benign and malignant melanocytic lesions
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 84
    DOI
  • Franklin, Cindy; Mohr, P.; Bluhm, L.; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, S.; Ugurel, Selma; et al.
    Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 29 – 30
    DOI
  • Sauter, D.; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, M.
    Konzept-basierte Erklärung neuronaler Netze für die Dermatohistopathologie
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 68
    DOI
  • Küper, Alisa; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Krämer, Nicole
    Mitigating Cognitive Bias with Decision Support Systems
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 64
    DOI
  • Jansen, P.; Zaremba, Anne; Philip, M.; Lodde, Georg; Livingstone, Elisabeth; Zimmer, Lisa; Ugurel, Selma; Paschen, Annette; Sucker, A.; Möller, I.; Landsberg, J.; Rose, C.; Emberger, M.; Schaller, J.; Plass, C.; Hadaschik, Eva; Schadendorf, Dirk; Mentzel, T.; Lutsik, P.; Griewank, Klaus
    Molekularpathologie und Methylierungsprofile als diagnostische Unterstützung zur Differenzierung von Klarzellsarkomen und melanozytären Tumoren
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 88
    DOI
  • Kreft, S.; Richter, L.; Peller, V.; Rieß, V.; Albrecht, L. J.; Müseler, A. C.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Partielle Remission auf Cemiplimab eines beidseitig Orbitae-infiltrierenden Basalzellkarzinoms des Mittelgesichts
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 44 – 45
    DOI
  • Zaremba, Anne; Ferdinandus, J.; Zimmer, Lisa; Umutlu, Lale; Seifert, R.; Barbato, F.; Ugurel, Selma; Chorti, E.; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic Melanoma
    31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, Hamburg, Germany and Virtual,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 75 – 76
    DOI (Open Access)
  • Bhave, Prachi; Hong, Angela; Johnson, Rebecca; Menzies, Alexander M.; Long, Georgina V.; Mangana, Joanna; Johnson, Douglas B.; Eroglu, Zeynep; Dulgar, Ozgecan; Yeoh, Hui-Ling; Haydon, Andrew; Lodde, Georg; Livingstone, Elisabeth; Khatak, Adnan; Kahler, Katharina; Hauschild, Axel; Wang, Wei (Tim); Carlino, Matteo
    Efficacy of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
    48th Annual Scientific Meeting Cancer care and research: Learning from the past and improving the future, 16-18 November 2021,
    In: Asia-Pacific Journal of Clinical Oncology: Wiley, Jg. 17, 2021, Nr. 9, SI, S. 162 – 163
    DOI (Open Access)